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“Siamo amanti e cultori di una sapienza umana che può 
considerarsi compiuta quando arriva a scorgere ciò che il senso rivela e ciò 
che si può desumere dalla similitudine, come i fenomeni percepiti per 
mezzo del senso. […]   
Noi non abbiamo seguito nient’altro che il senso e la natura, la 
quale, sempre in massimo accordo con se stessa, fa le stesse cose allo stesso 
modo e sempre produce i medesimi effetti.” 
 
 
De rerum natura iuxta propria principia (1586), 
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Astrosphere: astrocytes grown from embryonic induced stem cells. 
Credit: the laboratory of UW-Madison, Su-Chun Zhang, 2011. 
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1.1 Summary  
 
 
y starting observation was that that 
chronic exposure of hippocampal 
astrocytes to anti-nerve growth factor 
(NGF) antibodies is associated with early and progressive 
changes in astrocytic morphology reminiscent of reactive 
gliosis. Similar morphology changes are found in the 
hippocampal astrocytes from proNGF overexpressing 
M 
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transgenic mice and from Alzheimer’s 3XTg and 5xFAD mice 
at early stages of neurodegeneration. Interestingly, this 
phenotype can be rescued by intranasal NGF delivery to 3xTG 
and proNGF mice. 
These findings prompted us to investigate the 
mechanisms whereby interfering with the signalling of NGF 
causes astrocytes to undergo these changes.  
The astrocytic morphological alterations in mouse 
models of neurodegeneration were reproduced in vitro by 
culturing naïve hippocampal astrocytes with mAb αD11 anti-
NGF antibodies. These dramatic changes of astrocyte 
morphology are accompanied by robust transcriptomic 
changes at 8, 24 and 48 hours after anti-NGF administration, 
which identify a transcriptional fingerprint typical of reactive 
type A1 neurotoxic astrocytes70. Since cultured astrocytes 
express both TrkA and p75 NGF receptors and secrete NGF, 
I postulated that anti NGF antibodies disrupt a homeostatic 
autocrine or paracrine NGF signalling, inducing their 
transition to the A1 neurotoxic phenotype. 
I went on to investigate intracellular Ca2+ transients in 
astrocyte cultures. While NGF failed to reveal any effect on 
Ca2+, anti NGF potently induced within 5 minutes large 
intracellular Ca2+ transients, from ER intracellular stores. 
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Chemogenetic experiments indicate that the antiNGF-induced 
Calcium waves are TrkA-mediated. 
The functional consequences of anti NGF treatment of 
astrocytes on neuronal physiology were studied in 
hippocampal astrocyte-neuronal co-cultures. In these 
conditions, anti NGF treated astrocytes induced a strong Ca2+ 
activity in hippocampal neurons, ultimately leading to massive 
neuronal death. 
In conclusion, I have demonstrated that, in vitro and in 
vivo, astrocytes are sensors of ambient levels of NGF and 
respond to reduced levels of NGF by the activation of a 
strong and rapid Ca2+ response that eventually leads them to 
assume a A1 neurotoxic phenotype and negatively impact 
neuronal physiology and brain homeostasis.          
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1.2 More on NGF and AD   
 
The role of NGF in neurodegeneration has an old root, 
linked to its pro-survival and phenotypic maintenance action 
on cholinergic neurons of the basal forebrain. The discovery 
that other cells in the brain, besides neurons, like glial cells, 
could respond to NGF and modulate the neuronal physiology 
broadened the possible NGF targets to potentially all the 
brain, boosting the comprehension of some pathologies - like 
Alzheimer disease - and supporting new therapeutic strategies.  
Here I propose, based on my experiments, a new 
mechanism whereby astrocytes can sense locally the NGF 
level. They respond to a decrease in extracellular NGF, 
potentially triggering an activation loop sustained by an 
increase in calcium oscillations that can cause astrocytes to 
become active and change their morphology.  
First experimental evidence reveals that in a short time 
these paradoxically active astrocytes, when co-cultured with 
neurons, determine an increase of calcium transients in 
neurons as well, leading them to death.  
More experiments are necessary to unveil these 
proposed mechanisms and go deeper in the comprehension of 
astrocyte physiology, but the framework established by the 
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experiments presented in this PhD thesis allow future 
experiments to be grounded on a solid basis. 
 
1.3 NGF and Alzheimer’s Disease   
 
NGF is not translated as such, but as a pre-pro-protein 
which is cleaved, typically by furin enzyme, in the trans-Golgi 
network to yield mature NGF71. ProNGF was initially thought 
to be simply a chaperone to allow NGF to be folded and 
mature NGF to be finally secreted. ProNGF can also be 
released as such and represents the major form of NGF in the 
brain73 and can be cleaved extracellularly by plasmin and 
matrix metalloproteases72. ProNGF and NGF have distinct 
biological activitie43: proNGF has a higher affinity for p75NTR 
and a lower one for TrkA compared to mature NGF and 
induces p75NTR-dependent apoptosis.  
ProNGF can also induce TrkA-dependent neuronal 
survival, although less effectively than NGF73.  
The pro-domain of NGF interacts with sortilin, a 
neuronal type-1 VPS10-domain receptor, a co-receptor with 
p75NTR for proNGF74. Sortilin, together with the VPS10-
containing protein sorLA, binds the retromer complex in 
neurons.  
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The levels of proNGF and of its coreceptor sortilin 
increase in mild cognitive impairment and early AD brains90, 
paralleling the progressive decline in TrkA receptors. A 
diminished conversion of proNGF to mature NGF and an 
increased NGF degradation in AD brains was definitely 
reported72. 
Thus, the biological effects of proNGF versus NGF 
influence the balance between cell death and cell survival74, 75 
and an imbalance in this complex ligand/receptor system has 
been correlatively linked to AD neurodegeneration, although 
no causally direct proof in vivo is available. 
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1.4 The AD11 mouse   
 
 
NGF (Levi-Montalcini, 1952) is required for the 
differentiation and the survival of specific neuronal 
populations during development, including sensory, and 
sympathetic neurons in the peripheral nervous system       and 
basal forebrain cholinergic neurons in the central nervous 
system (Levi-Montalcini, 1987). NGF also exerts actions on 
non-neuronal cell populations (Levi-Montalcini, 1987).  
After the early use of anti-NGF antibodies (Levi-
Montalcini and Booker 1960), NGF functions in vivo have 
been investigated with different approaches, including the 
systemic (Levi-Montalcini and Angeletti, 1966; Gorin and 
Johnson, 1979, 1980) or local (Li et al., 1995; Van der Zee et 
al., 1995; Molnar et al., 1998) delivery of anti-NGF antibodies 
and the disruption of the NGF gene, by homologous 
recombination, in transgenic mice (Crowley et al., 1994).  
The embryonic ablation of NGF function gives rise to a 
lethal phenotype in the early postnatal period, preventing the 
analysis of NGF function in adult animals. On the other hand, 
adult heterozygous NGF knockout mice show only a mild 
cholinergic phenotype and no other described deficits (Chen et 
al., 1997). 
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Given the potential clinical relevance of some of the 
described actions of NGF, the use of specific and not-lethal 
models represents a desirable tool. 
After the demonstration that recombinant antibodies 
can be efficiently secreted by cells of the nervous system 
(Cattaneo and Neuberger, 1987), a novel approach for 
phenotypic knockout, the neuroantibody approach, has been 
proposed and validated (Piccioli et al., 1991, 1995). 
 
With all these pivotal assumptions, a transgenic mouse that lacks 
enough mature nerve growth factor was generated, and, among the relevant 
outcomes, it suffers from a progressive AD-like syndrome. Moreover, the 
delivery of NGF or of a cholinergic agonist were able to reduce the 
pathology. 
 
The mouse model, called AD11, was created to explore 
the possibility that the death of basal forebrain cholinergic 
neurons in Alzheimer's disease is related to reductions in nerve 
growth factor levels. AD11 was created by inserting a gene 
that expresses an anti-NGF antibody (formally, 2 genes for 
light and heavy chains), named αD11, that efficiently binds only 
the mature form of the neurotrophin (Ruberti et al. 2000, Paoletti 
et al., 2009) (fig 1.1).  
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Fig 1.1 Schematic representation of the proNGF/NGF imbalance 
model  
 
On the left side is the "normal" condition, when nerve growth 
factor (NGF) signaling is achieved mainly through the 
NGF/TrkA/p75NTR system. In the middle-right part of the scheme is a 
representation of the pathological conditions (middle, AD conditions; 
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right, AD11 model): in both cases, an imbalance in the proNGF/NGF 
ratio takes place.  
From Nerve Growth Factor and Alzheimer’s Disease: New 
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Capsoni, Cattaneo and their colleagues have described 
how the depletion of extracellular mature NGF in this model 
progressively recapitulates features of Alzheimer's disease. The 
AD11 mouse shows neuronal loss, tau hyperphosphorylation 
and insolubility, neurofibrillary tangle-like abnormalities, and 
behavioral deficits linked to cholinergic atrophy (Capsoni et al., 
2000).  
It also exhibits amyloid plaques (from the endogenous 
mouse amyloid precursor protein) (Capsoni et al. 2002), and 
deficits in cortical synaptic plasticity (Pesavento et al. 2002), all 
of which led Cattaneo and associates to propose this mouse as 
a comprehensive model for sporadic AD and, among the other 
numerous outcomes, identifying a novel mechanism of 
neurodegeneration induced by proNGF/NGF imbalance. 
In addition, in 2011 D’Onofrio et al. showed that, in 
these mice, the onset of neuroinflammation was preceding the 
appearance of tau hyperphosphorylation and amyloid plaques.  
 
This prompted us to study the effects of NGF 
deprivation on one cell type involved in neuro-
inflammation: the astrocyte.  
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“It’s a crowded party in the body, and biologists want to see what’s going on” 
From “A Brain in a Plate?” 
Credit: Jan Schmoranzer. 
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2. General background   
 
2.1 The fall of idols  
 
he neuron-centred view of the past 
disregarded or downplayed the role of 
astroglia as a primary component in the 
pathogenesis of neurological diseases.  
As this concept is changing, so is also the perceived role 
of astrocytes in the healthy and diseased brain and in the spinal 
cord. Researchers have started to unravel the different 
signalling mechanisms that trigger specific molecular, 
morphological and functional changes in astrocytes and that 
may be critical for repairing tissue and maintaining function in 
T 
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CNS pathologies, such as neurotrauma, stroke, or 
neurodegenerative diseases. An increasing body of evidence 
shows that the effects of astrogliosis on the neural tissue and 
its functions are not uniform or stereotypic but vary in a 
context-specific manner. Indeed, astrogliosis can be an 
adaptive beneficial response under some circumstances but 
also a maladaptive and deleterious process in another context.  
There is a growing support for the concept of 
astrocytopathies in which the disruption of normal astrocyte 
functions, astrodegeneration or dysfunctional/maladaptive 
astrogliosis are the primary cause or the main factor in 
neurological dysfunction and disease. For this, reason, there is 
a big interest in the mechanism of dysfunctional/maladaptive 
astrogliosis and on the factors that execute the toxic actions of 
astrocytes in neurodegeneration conditions. This thesis 
proposes a new homeostatic mechanism of astrocytes in the 
healthy CNS describing how they could react to an unbalance 
of NGF/proNGF in the microenvironment around them. 
This finding increases the diversity of astrocytes 
responses in neurological disorders and argues that targeting 
astrocytes may represent an effective therapeutic strategy for 
Alzheimer Disease (AD) as well as other neurodegenerative 
diseases. 
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2.2 Astrocytes in the brain: beyond scaffold cells  
 
It is nowadays well understood  that astrocytes cannot 
be just be considered as scaffold cells deputed to feed and 
preserve neuronal activity but, since they are involved in a 
large number of functions, they are critical to the performance 
of the Central Nervous System (Verkhratsky et al., 2014; Gallo 
et al., 2014).  
It is more and more evident that the peculiar properties 
of these cells can actively contribute to the extraordinary 
complexity of the brain and, on the other hand, to the 
dysfunctions and diseases classically related to other cell types, 
especially neurons (Allen et al., 2009; Lin et al., 2012). 
New evidence indicates that astrocytes could really make 
the difference in mammalian brain evolution (Molofsk et al., 
2012), corroborated by the impressive discovery that mice 
enhance some behavioural aspects if expressing human 
astrocytes (Zang et al., 2013; He et al., 2015). 
The essential and various functions astrocytes provide 
include i) homeostasis of extracellular ions, pH, idratation 
(Simard et al., 2004); ii) uptake and clearance of 
neurotransmitters (Schousboe et al., 2004; Yi et al., 2006); iii) 
energy and metabolism (Allaman et al., 2011); iv) blood flow 
regulation(Attwell et al., 2010); v) neuronal activity 
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coordination and synaptic functions (Clarke et al., 2013; 
Halassa et al., 2010; Bergami et al., 2008; Bazargani et al., 
2016). 
If a large number of evidences are now reported 
regarding how these functions might involve astrocyte 
specialization and heterogeneity, the degree to how astrocytes 
maintain or modulate their participation in these functions, or 
adopt new functions, is not well understood (Anderson et al., 
2014; Colangelo et al., 2014; Trias et al., 2013; Wyss-Coray et 
al., 2002). 
As mentioned before, some aspects traditionally related 
to neuronal degenerative pathologies, together with some well 
described neuronal physiological properties, could be 
reasonably re-interpreted keeping in mind that astrocytes, and 
their contribution, might have been underestimated  
A large number of in vitro studies on bona fide neuronal 
preparations include de facto astrocytes, due to the difficulties to 
obtain really pure neuronal cultures. Obviously, astrocytes are 
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With the aim of addressing this need, and of turning 
these limitations into new perspectives,  
 
to explore if and how astrocytes could react to 
proNGF/NGF imbalance and, eventually, influencing 
the neuron homeostasis,  
 
I took advantage from our AD11 mouse model, in 
which the expression of the recombinant αD11 anti Nerve 
Growth Factor (NGF) antibody causes an imbalance between 
the mature and immature form of NGF.  
This lead, progressively, to a generalized Alzheimer-like 
phenotype (Ruberti et al. 2000; Capsoni et al., 2000 and 2002) 
overcoming the concept that the “classical” neuronal target 
cells for NGF could appear a limiting factor for the model 
acceptancy (Cattaneo et al., 2008). 
The glia cells (microglia and astrocytes) could be the 
target cells contributing to explain this widespread effect.  
The link between Alzheimer's disease and astrocytes is 
well described and is based on several components: they can 
take up Aβ, they are involved in plaque progression with death 
of Aβ loaded astrocytes giving rise to secondary plaques 
(Nagele et al., 2004); astrocytes have a modulatory effect on 
neuroinflammation27, on neuron-neuron communication16 and 
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on tripartite (more recently, quadripartite) synapses28,29. In this 
study, I describe a new way by which astrocytes can respond to 
a change in brain homeostasis such as NGF local acute 
deprivation.  
In presence of a decrease in the level of NGF astrocytes 
become active and modify their morphology. I propose also a 
new way they could influence neuronal activity and cause 
neuronal death. 
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The multi-partite synapse of the CNS represents a 
striking example of such a specialization (fig 2.1) with pre- and 
post-synaptic membranes being packed with exocytotic 
machinery, neurotransmitter receptors and proteins 
responsible for plasticity, whereas all “homeostatic” molecules 
(i.e. transporters and enzymes responsible for ion and 
transmitter homeostasis in the synaptic cleft, for transmitter 
catabolism, for metabolic support, etc.) being localized in the 
perisynaptic astrocytic processes .  
The synaptic assembly also includes a microglial cell 
process that frequently senses the synapse status. Already at 
this elementary level of CNS organization, the cellular 
functions are divided. Neuronal compartment assures fast 
information flow whereas glial elements ascertain functional 
isolation and support of synapses, maintain synaptic operation 
through regulation of homeostasis and control synaptic 
survival or elimination depending on the network demands. 
 






Fig 2.1 Multipartyte synapse involving several CNS players.  
This simplified model illustrates LTP, which relies on the 
NMDAR-dependent insertion of GluA1-containing AMPA receptors 
at the postsynaptic surface. In this model communication via cytokines is 
depicted by arrows, which can bi-directionally connect multiple cell 
populations.  
Cytokine networks enable local interactions between neuronal and 
non-neuronal cells (e.g., astrocytes, microglia, vascular endothelial cells) in 
the brain, as well as brain-periphery communication via the brain-blood 
barrier (BBB) and the choroid plexus (CP).  
The BBB releases cytokines and regulates the flux of cytokines 
from the blood; the CP produces cerebrospinal fluid (CSF) and cytokines 
and regulates the transport of cytokines and immune cells from blood 
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vessels. LTP modulation by cytokines has been widely studied, however, 
for most cytokines, is unclear if they modulate LTP by directly targeting 
synapses (one-direction arrows) or by indirect mechanisms relying on 
cytokine networks maintained by non-neuronal cells interactions.  
Cytokines can induce the expression and release of multiple 
cytokines in their target cells, thus activating cytokine networks, which 
could modulate synaptic transmission by targeting synapses via both 
cytokine-dependent and -independent mechanisms (dotted arrows) From 
Prieto and Cotman 2017. 




The very same specialization is observed at all levels of 
CNS organization. Neurons fire and establish multiple 
contacts whereas neuroglia control local micro-environment 
and protect neural tissue. In the grey matter, astrocytes divide 
(through the process known as tiling that starts in late 
embryogenesis) the parenchyma into relatively independent 
units traditionally known as neurovascular units, and recently 
often called astrogliovascular units, that integrate, within an 
individual astroglial territorial domain, neural and vascular 
elements. By employing a wide array of molecular mechanisms 
such as exocytosis, diffusion through plasmalemmal channels 
or membrane transporters, astrocytes secrete numerous 
neurotransmitters, neurohormones and trophic factors that 
regulate synaptic fields, neuronal groups and signal to other 
cellular elements (e.g. microglia, oligodendroglia, pericytes, 
endothelial cells).  
At the level of the whole brain, astrocytes form glia 
limitans regulate emergence and function of brain–blood and 
brain–cerebrospinal fluid barriers and contribute to overall 
brain metabolism being the sole producers and repository of 
glycogen 
The homeostatic function of astroglia is linked to their 
neuroprotective capabilities, as indeed astrocytes are principal 
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elements of CNS defence. Insults to the CNS, regardless of 
their aetiology, strain the organ homeostasis and in this case 
astrocytes, through dedicated molecular cascades, protect 
neurons against glutamate excitotoxicity, extracellular K+ 
overload, reactive oxygen species, and these are also astrocytes 
that supply stressed neurons with energy substrates.  
The loss of these critical astroglial functions permits and 
exacerbates progression of various diseases, of which 
amyotrophic lateral sclerosis, toxic encephalopathies or 
Alzheimer’s disease (AD) are prominent examples. Defensive 
function of astrocytes is manifested as reactive astrogliosis, a 
multi- component and complex remodelling of astroglia 
triggered by lesions to the CNS. Astrogliosis is an important 
component of cellular pathophysiology and its suppression 
often aggravates neuropathology. 
SYNOPSIS - NMC - SNS 
34 
 
Mouse Astrocytes, cortex.  
Credit: Dr. Nybertuc. 
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3. Natural history of 
neuroglia  
 
“THE NEUROGLIA is the delicate connective tissue which 
supports and binds together the nervous elements of the central nervous 
system. One part of it, which lines the central canal of the cord and 
ventricles of the brain, is formed from columnar cells, and is called 
ependyma, while the rest consists of small cells with numerous processes 
which sometimes branch and sometimes do not.” 
Encyclopaedia Britannica, 1910, 11th Ed., v. 19, p. 401  
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“As the Greek name implies, glia are commonly known as the 
glue of the nervous system; however, this is not fully accurate. Neuroscience 
currently identifies four main functions of glial cells: to surround neurons 
and hold them in place, to supply nutrients and oxygen to neurons, to 
insulate one neuron from another, and to destroy pathogens and remove 
dead neurons. For over a century, it was believed that they did not play 
any role in neurotransmission. That idea is now discredited; they do 
modulate neurotransmission, although the mechanisms are not yet well 
understood.”  
Glial Physiology and Pathophysiology, First Edition. 
2013 
 
3.1 Neuroglia: from glue to glory 
 
o the continual surprise of everybody 
working in neuroglial research, the proper 
characteristics and capabilities of neuroglia are 
still a matter of debate. Many existing definitions highlight the 
supportive role of these cells, and some are based on the 
process branching and delicate morphology of these cells, but 
the most common definition assigned to neuroglia is “cells 
residing in the brain that are not electrically excitable neurons 
or vascular cells”. 
T 
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As a result, neuroglia has become a generalised term that 
covers cells with different origins (ectodermal for macroglia 
and mesodermal for microglia), morphology, physiological 
properties and functional specialisation. Indeed, in the Central 
Nervous System (CNS), neuroglia include the cells of the 
choroid plexus, the oligodendrocytes, the ependymal cells, the 
radial glia of the retina, the immunocompetent 
microglia/innate macrophages and the hugely diverse 
astrocytes; whereas, in the peripheral nervous system (PNS), 
they include the diverse kinds of Schwann cells, satellite glia, 
olfactory ensheathing cells and the highly numerous enteric 
glia.  
There is, however, one unifying fundamental property 
common for all these cell types and this is their ultimate 
function: homeostasis of the nervous system.  
The evolution of the nervous system led to a 
specialisation of neurons, which become perfect elements for 
signalling and information processing. This came at the price 
of losing essential housekeeping functions, as neurons are 
generally incapable of regulating their own immediate 
environment and are vulnerable to many kinds of 
environmental insults. These main housekeeping functions 
went to the neuroglia, which have specialised themselves into 
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many types of cells to perform specific aspects of nervous 
system homeostasis. 
This homeostatic function of neuroglia is executed at 
many levels, and includes: whole body and organ homeostasis 
(e.g. astrocytes control the emergence and maintenance of the 
CNS, peripheral glia are essential for communication between 
the CNS and the body, and enteric glia are essential for every 
aspect of gastrointestinal function);  
i) cellular homeostasis (e.g. astroglia and microglia);  
ii) morphological homeostasis (glia define the 
migratory pathways for neural cells during development, shape 
the nervous system cyto-architecture and control 
synaptogenesis/synaptic pruning, whereas myelinating glia 
maintain the structural integrity of nerves);  
iii) molecular homeostasis (which is represented by 
neuroglial regulation, of ion, neurotransmitter neurohormone, 
and neurotrophic factor concentrations in the extracellular 
spaces around neurons);  
iv) metabolic homeostasis (e.g. neuroglial cells store 
energy substrates in a form of glycogen and supply neurons 
with lactate);  
v) long-range signalling homeostasis (by myelination 
provided by oligodendroglia and Schwann cells);  
                                                                                    NATURAL HISTORY OF NEUROGLIA - NMC - SNS 
 
 
                                                              39 
 
vi) defensive homeostasis (represented by astrogliosis 
and activation of microglia in the CNS, immune reactions of 
enteric glia; all these reactions provide fundamental defence 
for neural tissue).  
Moreover, some neuroglial cells act as chemosensitive 
elements of the brain that perceive systemic fluctuations in 
CO2, pH and Na+ and thus regulate behavioural and systemic 
homeostatic physiological responses.  
Therefore, the neuroglia can be broadly defined as 
homeostatic cells of the nervous system, represented by highly 
heterogeneous cellular populations of different origin, 
structure and function.  
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3.2 Classification of neuroglia 
 
Generally, see the scheme below, the neuroglia in the 
mammalian nervous systems are sub classified into peripheral 
nervous system (PNS) glia and central nervous system (CNS) 
glia.  
 
Fig 3.1 The neuroglia in the mammalian nervous system  
From Verkhratsky 2013. 
 
The PNS glial cells which surround neurons in 
peripheral ganglia are known as satellite glial cells, and those in 
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the olfactory system are known as olfactory ensheathing cells. 
Finally, the PNS includes enteric glia, which reside in the 
enteric nervous system. 
CNS glia are generally subdivided into astrocytes, 
oligodendrocytes, NG2-glia and microglia. Astrocytes are the 
main homeostatic cells of the gray matter. Oligodendrocytes 
are the myelinating cells in the CNS and NG2-glia act as 
oligodendroglial precursors.  
 
Fig 3.2 The evolutionary origins of glial cells 
From Verkhratsky 2013. 
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The early evolution of the nervous system can only be 
speculated upon, because fossils do not provide much material 
for analysis, and it is likely that many early life forms have not 
survived to our time. Nonetheless, certain generalisations can 
be drawn and overall, we are in possession of a rather logical 
system of views on the milestones of nervous system 
phylogeny.  
There are some indications that glia have appeared in 
phylogeny on several occasions, and parallel evolution is likely. 
There is no evidence for the existence of glial cells in diffuse 
nervous systems and no cells associated with neurons or their 
processes have been detected in the comb jellies. Similarly, no 
glial cells were found in Cnidaria polyps, with the exception of 
scyphomedusae, in which some glia-like cells were apparently 
reported from Hartline in 2011, but neither their function nor 
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3.3 Phylogenetic importance of neuroglia 
 
 
Fig 3.3 Glia/neurons ratio: a panoramic view  
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(a) Glia-to-neuron ratio in the nervous system of invertebrates and 
in the cortex of vertebrates. Glia-to-neuron ratio is generally increased in 
phylogeny; this ratio more or less linearly follows an increase in the size of 
the brain.  
 
(b) The glia/neuron ratio in the cortex of higher primates; this 
ratio is highest in humans (From Sherwood et al., 2006).  
 
(c) Graphic representation of neurons and astroglia in mouse and 
in human cortex. Evolution has resulted in remarkable changes in 
astrocytic dimensions and complexity.  
 
(d) Relative increase in glial dimensions and complexity during 
evolution. Linear dimensions of human astrocytes, when compared with 
mice, are .ca 2.75 times larger, and their volume is 27 times larger; 
human astrocytes have .ca 10 times more processes and every astrocyte in 
human cortex enwraps .ca 20 times more synapses.  
 
(c) From Oberheim et al., 2006.  
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Most probably, neuroglia appeared with the emergence 
of a centralised nervous system, when neurons acquired 
specialisation and subsequently began to amass into sensory 
organs and ganglia. The very first glial cells are associated with 
sensory organs and have the same epithelial origin as neurons. 
More advanced and much more characterised are glial cells in 
nematodes, as extensively studied in Caenorhabditis elegans. 
The brains of primates contain specific astroglial cells 
which are absent in other vertebrates. Most notable of these 
are the interlaminar astrocytes, which reside in layer I of the 
cortex; this layer is densely populated by synapses but almost 
completely devoid of neuronal cell bodies. These interlaminar 
astrocytes have a small cell body (10 mm), several short and 
one or two very long processes. The latter penetrate through 
the cortex and end in layers III and IV; these processes can be 
up to 1 mm long. The endings of the long processes create a 
rather unusual terminal structure, known as the ‘terminal mass’ 
or ‘end bulb’, which is composed of multilaminar structures 
containing mitochondria. 
Incidentally, the processes of interlaminar astrocytes and 
size of “terminal masses” were particularly large in the brain of 
Albert Einstein (Colombo et al., 2006). 
The function of these interlaminar astrocytes remains 
completely unknown, although it has been speculated that they 
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are the astroglial counterpart of neuronal columns, which are 
the functional units of the cortex, and that they may be 
responsible for a long-distance signalling and integration 
within cortical columns. Interestingly, inter- laminar astrocytes 
are altered in Down syndrome and Alzheimer’s disease. 
Human brains also contain polarized astrocytes, which 
are uni- or bipolar cells that dwell in layers V and VI of the 
cortex, quite near to the white matter; they have one or two 
very long (up to 1 mm) processes that terminate in the 
neuropil. The processes of these cells are thin (2–3 mm in 
diameter) and straight, and they also have numerous 
varicosities. Once more, the function of polarized astrocytes 
remains enigmatic, although they might be involved in para-
neuronal long-distance signalling. 
The evolution of neurons produced fewer changes in 
their appearance – that is, the density of synaptic contacts in 
rodents and primates is very similar (in the rodent brain, the 
mean density of synaptic contacts is about 1397 millions/mm3, 
which is not much different from humans, where synaptic 
density in the cortex is about 1100 millions/mm3). Similarly, 
the number of synapses per neuron does not differ 
significantly between primates and rodents.  
The shape and dimensions of neurons also have not 
changed dramatically over the phylogenetic ladder. Human 
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neurons are certainly larger, yet their linear dimensions are 
only about 1.5 times greater than in rodents. Thus, at least 
morphologically, evolution resulted in far greater changes in 
glia than in neurons. Most likely this fact has important, 
although yet undetermined, significance. 
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Astrocyte cells in the brain of a human fetus.  
Credit: Dr Amjad. 
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4. The Astrocyte 
 
4.1 Unsuspected heterogeneity  
 
enerally, astrocytes arguably are the most 
diverse glial cells in the CNS. They are 
variable among different areas and also 
within the same region. The classic most generally 
acknowledged definition of astrocyte is based on the 
morphology and on the expression of specific astroglial 
markers. Indeed, it is commonly believed that an archetypal 
G 
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feature of astrocytes is their expression of intermediate 
filaments, which form the cytoskeleton. The main types of 
astroglial intermediate filament proteins are Glial Fibrillary 
Acidic Protein (GFAP) and vimentin; expression of GFAP is 
commonly used as a specific marker for identification of 
astrocytes.  
The astrocyte is therefore generally defined as a cell with 
star-like appearance expressing GFAP. In reality, most of the 
astrocytes do not have a star-like morphology and many 
astrocytes do not express GFAP. Indeed, the normal levels of 
GFAP expression vary quite considerably between brain 
regions. For example, GFAP is expressed by virtually every 
Bergmann glial cell in the cerebellum and by fibrous astrocytes 
in white matter, whereas only about 15–20 percent of 
protoplasmic astrocytes express GFAP in the cortex of mature 
animals. In general, the name ‘astroglia’ is an umbrella term 
that covers many types of glial cells.  
Some astrocytes do, indeed, have a star-like appearance, 
with several primary (also called stem) processes originating 
from the soma, although most of them have more complex 
morphology.  
i) Possibly the largest groups of astrocytes are 
represented by the protoplasmic astrocytes and fibrous astrocytes 
of the grey and white matter, respectively.  
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ii) The second big group of astroglial cells is the 
radial glia. These are bipolar cells with an ovoid cell body and 
elongated processes. Radial glia usually produce two main 
processes, one of them forming endfeet on the ventricular wall 
and the other at the pial surface. They are a common feature 
of the developing brain, as they are the first cells to develop 
from neural progenitors. From very early embryonic stages, 
radial glia also form a scaffold which assists neuronal 
migration. After maturation, radial glia disappear from many 
brain regions and transform into stellate astrocytes, although 
radial glia-like cells remain in the retina (Müller glia) and the 
cerebellum (Bergmann glia).  
iii) In addition to the two major groups of astroglial 
cells, there are smaller populations of specialised astroglia 
localised to specific regions of the CNS, namely the velate 
astrocytes of the cerebellum, the interlaminar and polarised astrocytes 
of the primate cortex, tanycytes (found in the periventricular 
organs, the hypophysis and the raphe part of the spinal cord), 
pituicytes in the neuro-hypophysis, and perivascular and marginal 
astrocytes.  
iv) Astroglia also include several types of cells that 
line the ventricles or the subretinal space, namely ependymocytes, 
choroid plexus cells and retinal pigment epithelial cells. 
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All these diverse cell types differ in their morphology 
and gene expression, in physiological properties, sensitivity to 
various neurotransmitters and finally in functional features. 
Studies over recent decades have found that astrocytes from 
different brain regions differ substantially in expression of 
genes for the most fundamental proteins responsible for glial 
function, including genes encoding ion channels and 
neurotransmitter receptors, glutamate, GABA and glycine 
transporters, for nitric oxide synthase and for enzymes 
metabolising dopamine and serotonin (monoamine oxidase) 
and GABA (GABA transaminase).  
Physiological experiments in vitro, in situ and in vivo have 
revealed similar regional differences throughout the brain for 
the functional expression of ion channels and neurotransmitter 
receptors, the latter most likely being regulated by the local 
neurotransmitter environment (Verkhratsky et al., 1998, 2011). 
Identification of astrocytes, therefore, requires a rather 
complex set of criteria, which is difficult not only because of 
the huge astroglial heterogeneity, but also due to 
developmental changes in astroglial phenotype and because of 
the wide presence of NG2-glia, which in some past studies 
were considered a subtype of astrocyte.  
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4.2 Defining an astrocyte: common properties 
 
In some systematic studies, Harald Kimelberg 
(Kimelberg, 2009, 2010) has elaborated eight criteria for 
identifying astrocytes, as follows: 
 
i) Absence of electrical excitability (i.e. astrocytes 
cannot generate action potential). 
ii) A very negative membrane potential (-80 to -90 
mV) because of a prevalence of K+ permeability of the 
plasmalemma; the membrane of astrocyte behaves as an 
almost ideal K+ electrode. 
iii) Functional expression of transporters for GABA 
and glutamate that permits the astroglial role in 
neurotransmitter homeostasis. 
iv) A large number of intermediate filament bundles, 
which are the sites of the astrocyte specific protein GFAP. 
v) Glycogen granules. 
vi) Processes from each cell contacting and 
surrounding blood vessels. 
vii) Elaborated perisynaptic processes.  
viii) Linkage to other astrocytes by gap junctions 
formed by connexin 43 and/or 30. 




This classification, although being straightforward and 
conceptually simple, omits too many classes of cells that share 
functional properties considered fundamental and defining for 
astrocytes. This fundamental property of astrocytes is the 
maintenance of CNS homeostasis. In this respect, the family 
of astrocytes can be functionally defined as the homeostatic 
cells of the CNS that provide for molecular, cellular and organ 
homeostasis. 
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Fig 4.1 Morphological diversity of astrocytes throughout the brain. 
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Reconstructions from confocal images stacks of astrocytes taken 
from different regions of the brain and the spinal cord of the adult 
transgenic mouse expressing enhanced green fluorescence protein under 
control of glia-specific promoter. 
From Emsley and Macklis, 2006. 
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Fig 4.2 An astrocyte in culture  
An astrocyte cell grown in tissue culture stained with antibodies to 
GFAP and vimentin. The GFAP is coupled to a red fluorescent dye and 
the vimentin is coupled to a green fluorescent dye. Both proteins are present 
in large amounts in the intermediate filaments of this cell, so the cell 
appears yellow, the result of combining strong red and green signals. The 
blue signal is DNA revealed with DAPI and shows the nucleus of the 
astrocyte and of other cells in this image. Image was captured on a confocal 
microscope in the EnCor Biotechnology laboratory. 
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4.3 Morphology of the main type of astrocyte 
 
Some classical staining techniques, such as Golgi 
impregnation or gold chloride sublimate staining method of 
Cajal, as well as immunohistochemical staining with GFAP 
antibodies (fig 4.1) have provided oversimplified images of 
protoplasmic astrocytes. These techniques mostly revealed the 
main astroglial processes, which contributed to our image of 
astroglia as star-like cells. The introduction of staining 
techniques that utilised either filling astrocytes with fluorescent 
dyes, staining with rhodamine 101 (which preferably 
accumulates in the astrocyte cytosol), or using targeted 
expression of cytoplasmic fluorescent proteins, have 
revolutionised morphological studies of astroglia. Indeed, 
protoplasmic astrocytes have an incredibly complex 
arborisation of processes that cannot be seen so deeply by 
GFAP immunolabeling.  
The bulk of this arborisation is made of short, feather-
like, ultra-fine and extensively ramified processes, 2–10 um 
long, extending from principal processes to endow 
protoplasmic astrocytes with a spongiform appearance.  
These fine processes also exhibit rapid structural 
plasticity, especially at the sites contacting to synapses, where 
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astrocytes extend lamellipodia-like membrane protrusions 
along neuronal surfaces, or filopodia-like extensions, which 
protrude and retract within tens of seconds (Hirrlinger et al., 
2004). The arborisation of protoplasmic astrocytes delineates 
discrete territorial domains, and there is little overlap (<10 %) 
between neighbouring cells. On average, protoplasmic 
astrocytes in rodent hippocampus of rats occupy the volume 
of ≈43,000–66,000 mm3 (Bushong et al., 2002; Wilhelmsson et 
al., 2006). The process surface area of protoplasmic astrocytes 
may reach up to 80,000 mm2 and cover most of neuronal 
membranes within their domain. Some processes of 
protoplasmic astrocytes contact blood vessels, forming so-
called perivascular endfeet, and some protoplasmic astrocytes 
also send processes to the pial surface, where they form 
subpial endfeet, which contribute to glia limitans. 
The density of protoplasmic astrocytes is different in 
various brain regions. A single protoplasmic astrocyte in 
rodent cortex contacts 4–8 neurons, surrounds ≈300–600 
neuronal dendrites and provides cover for up to 20,000–
120,000 synapses residing within its domain (Bushong et al., 
2002; Halassa et al., 2007b). 
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4.4 Human astrocytes 
 
Human protoplasmic astrocytes are 2–3 times larger and 
exceedingly more complex; the processes of a single human 
protoplasmic astrocyte cover approximately 2 million synapses. 
The morphology of protoplasmic astrocytes across the brain is 
highly heterogeneous. Even within the same CA1 hippocampal 
area, protoplasmic astrocytes have different shapes, with sub-
populations of fusiform cells, spherical or markedly elongated 
astrocytes (Bushong et al., 2002). Protoplasmic astrocytes in 
the entorhinal cortex are elongated cells with several main 
processes, whereas astrocytes in other brain regions have 
distinctly different morphology.  
These differences are clearly revealed by both 
immunocytochemistry with GFAP (which visualises 
cytoskeleton) and with genetically targeted green fluorescent 
protein (that is distributed within the cytosol and therefore 
also shows fine processes). 
Polarised astrocytes are a class of cells possibly confined to 
the brains of primates, which are positioned in the deep 
cortical layers very near to the white matter. These cells have 
one or two long (up to 1mm in length) processes that 
penetrate into superficial cortical layers.  
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Also the varicose projection astrocytes appear to exist only 
in the brains of humans. These cells are characterised by 
several (up to 5) long (up to 1 mm) unbranched processes that 
extend in all directions through the deep cortical layers. These 
processes are endowed with evenly spaced varicosities. Once 
more, the role of these types of cells remains unknown. 
In addition to these classical astrocytes, more types of 
astroglia, represented by radial-like glia and glia in specific 
organs, are distinguished in the brains of humans and, more in 
general, of mammals. 
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Fig 4.3 Visualisation of astrocytes with different techniques 
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A,B. Human astrocytes stained by Golgi method 
(A: reproduced from Retzius, 1894; B: drawing of Cajal). 
 
C. Hippocampal mouse astrocyte stained with antibody against 
GFAP. 
D. Similar mouse hippocampal astrocyte stained with antibody 
against astroglia-specific enzyme, glutamine synthetase. 
(C & D both from Olabarria et al., 2011). 
 
E. A single astrocyte labelled with enhanced green fluorescent 
protein (eGFP). The fine intricate processes of protoplasmic astrocytes are 
visualised by eGFP fluorescence. Insert shows the eGFP labelled astrocytic 
processes in higher magnification. The astrocytes were transfected in situ by 
an intracortical injection of adenoviral eGFP. The brains were processed 
for histology 2–4 days later. 
(From Wilhelmsson et al., 2006). 
 
F. Image of hippocampal astrocyte injected with fluorescent dye 
Alexa Fluor 568; dye filling reveals a cloud of fine spongiform processes. 
(From Nedergaard, et al., 2010). 
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Differentiation of multipotent human neural progenitor cells into astrocytes. 
Credit: NIH.
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5. Astrocytes in Action 
 
5.1 The tripartite synapse 
 
wenty-five years ago, the term tripartite synapse 
was proposed to conceptualize the evidence 
obtained by many laboratories during the 
1990s that revealed the existence of bidirectional 
communication between neurons and astrocytes. 
It represents a concept in synaptic physiology wherein, 
in addition to the information flow between the pre- and 
postsynaptic neurons, astrocytes exchange information with 
the synaptic neuronal elements, responding to synaptic activity 
and regulating synaptic transmission. 
T 






Fig 5.1 Views of the neuron–astrocyte interaction at the tripartite 
synapse level.  
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(a) Cajal’s drawing showing ‘neuroglia’ of the pyramidal layer and 
stratum radiatum of the Ammon horn (from an adult man autopsied 
three hours after death).  
Original labels: A, large astrocyte embracing a pyramidal neuron; 
B, twin astrocytes forming a nest around a cell, C, while one of them sends 
two branches forming another nest, D; E, cell with signs of ‘autolysis’; F, 
capillary vessel.  
 
(b) Neuron and astrocyte stained with the Golgi method from a rat 
hippocampus. Inset: astrocyte and neuronal somas.  
 
(c) Electron microscopy image of astrocyte process at the axon–
spine interface: 
astrocyte process (astro, blue); postsynaptic density (psd, red); 
dendritic spine head (sp, yellow); axonal bouton (ax, green).  
 
(d) 3D reconstruction of a single astrocyte process (blue) 
interdigitating among four dendrites (gold, yellow, red and purple).  From 
Perera et al., 2009.  
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 The biology of astrocyte–neuron interaction has 
emerged as a rapidly expanding field and has become one of 
the most exciting topics in current neuroscience that is 
changing our vision of the physiology of the nervous system.  
The classically accepted paradigm that brain function 
results exclusively from neuronal activity is being challenged 
by accumulating evidence suggesting that brain function might 
actually arise from the concerted activity of a neuron–glia 
network. 
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5.2 Ca2+-mediated cellular excitability of astrocytes 
 
The astrocytic revolution in current neuroscience began 
in the early 1990s when pioneering studies used the 
fluorescence imaging techniques to monitor intracellular Ca2+ 
levels in living astrocytes. Those first studies30,31 revealed that 
cultured astrocytes display a form of excitability based on 
variations of the intracellular Ca2+ concentration. Until then, 
astrocytes had been considered as non-excitable cells because, 
unlike neurons, they do not show electrical excitability. Since 
these pioneering findings, subsequent studies performed in 
cultured cells, brain slices and, more recently, in vivo have 
firmly established the astrocyte excitability, which is 
manifested as elevations of cytosolic Ca2+ mainly as a result of 
the mobilization of Ca2+ stored in the endoplasmic reticulum. 
The elevated Ca2+ then acts as a cellular signal32. 
Whereas neurons base their cellular excitability on electrical 
signals generated across the plasma membrane, astrocytes base 
their cellular excitability on variations of Ca2+ concentration in 
the cytoplasm. 
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5.3 Astrocyte Ca2+ is controlled by synaptic activity 
 
Astrocyte Ca2+ elevations can occur spontaneously as 
intrinsic oscillations in the absence of neuronal activity and 
they can also be triggered by neurotransmitters released during 
synaptic activity, which is of crucial importance because it 
indicates the existence of neuron-to-astrocyte communication. 
The synaptic control of the astrocyte Ca2+ signal is based 
on the fact that astrocytes express a wide variety of functional 
neurotransmitter receptors. Many of these receptors are of 
metabotropic type, being associated with G proteins that, 
upon activation, stimulate phospholipase C and formation of 
inositol (1,4,5)-triphosphate (Ins(1,4,5)P3), which increases the 
intracellular Ca2+ concentration through the release of Ca2+ 
from intracellular Ins(1,4,5)P3-sensitive Ca2+ stores 16-21. 
Early studies using cultured cells showed that the 
astrocyte Ca2+ signal could propagate to neighbouring 
astrocytes as an intercellular Ca2+ wave involving dozens of 
cells4,5,22. The synaptically evoked as well as the spontaneous 
Ca2+ signal originates in spatially restricted areas called 
microdomains of the astrocyte processes, 24,25 from where it can 
eventually propagate intracellularly to other regions of the 
cell20,25,26. As a single astrocyte might contact up to 105 
synapses: the control of the spatial extension of the Ca2+ signal 
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could have relevant functional consequences for the 
physiology of the nervous system, because not all synapses 
covered by a single astrocyte are necessarily functionally locked 
to be similarly and simultaneously modulated.  
Therefore, differential neuromodulation of specific 
synapses would provide an extraordinary increase of the 
degrees of freedom to the system. 
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5.4 Astrocyte Ca2+ signal in vivo 
 
For many years, technical constraints limited astrocyte 
Ca2+ signal studies to cultured cells and brain slices. The recent 
use of novel imaging techniques, that is, two-photon 
microscopy and specific fluorescent dyes that selectively label 
astrocytes in vivo, enabled the study of astrocyte Ca2+ signals 
in the whole animal and has revealed important findings.  
First, reports from studies of rat, mouse and ferret have 
demonstrated that astrocytes in vivo exhibit intracellular Ca2+ 
variations, indicating that astrocyte Ca2+ excitability is not a 
peculiarity of slice preparations. Second, like in brain slices, 
astrocyte Ca2+ variations occur spontaneously 30-33 and are also 
evoked by neurotransmitters released during synaptic activity 
31,33-37, indicating that neuron-to-astrocyte communication is 
present in vivo.  
Finally, and of special relevance, astrocyte Ca2+ 
elevations might be triggered by physiological sensory stimuli. 
Indeed, stimulation of whiskers increased the astrocyte Ca2+ in 
the mouse barrel cortex33 (fig 5.2). 
Astrocytes of the sensory cortex also elevate their Ca2+ 
in response to a robust peripheral stimulation that is known to 
activate the locus coeruleus or to direct electrical stimulation 
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of this nucleus34, as well as during running behaviour in alert 
mice 35. Astrocytes from other brain regions also respond to 
stimuli of corresponding sensory modalities. Astrocytes in the 
visual cortex not only show Ca2+ elevations in response to 
visual stimuli but also the properties of these responses 
indicate the existence of distinct spatial receptive fields and 
reveal an even sharper tuning than neurons to visual stimuli37. 
 
 
Fig 5.2 Astrocyte Ca2+ signalling in brain slices and in vivo.  
Upper line: Pseudocolor images from rat hippocampal slices 
representing fluorescence intensities indicative of astrocyte Ca2+ levels before 
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(-5 s) and after (5 s, 20 s) electrical stimulation of Schaffer collaterals. 
Scale bar, 10 um.  
 
Lower line: Two-photon microscopy images of the in vivo astrocyte 
Ca2+ signal in the barrel cortex. Pseudocolor images represent fluorescence 
intensities indicative of astrocyte Ca2+ levels before (0 s) and after (9 s, 15 





In summary, astrocytes in vivo display Ca2+ excitability 
and respond to neuronal activity. Furthermore, because 
astrocytes in specific sensory areas respond to a variety of 
sensory stimuli, it is feasible that astrocytes participate in the 
brain representation of the external world. 
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5.5 Synaptic information processing by astrocytes 
 
 
In contrast to the view of astrocytes as passive elements 
that provide the adequate environmental conditions for 
appropriate neuronal function and that respond to 
neurotransmitters, simply performing a linear readout of the 
synaptic activity, experimental evidence supports the idea that 
astrocytes integrate and process synaptic information 
elaborating a complex nonlinear response to the incoming 
information from adjacent synapses.  
As previously affirmed, it is firmly established that 
astrocytes respond with Ca2+ elevations to synaptic activity. 
However, to understand the actual role of astrocytes in brain 
information processing, it is necessary to define whether the 
astrocyte Ca2+ signal passively results from different 
neurotransmitter concentrations attained during synaptic 
activity or, alternatively, whether neuron-to-astrocyte 
communication presents properties of complex information 
processing that are classically considered to be exclusive to 
neuron-to-neuron communication.  
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5.6 Astrocytes discriminate the activity of synaptic 
pathways 
 
The astrocyte Ca2+ signal does not result from a 
nonspecific spillover of neurotransmitters. Instead, it is 
selectively mediated by the activity of specific synaptic 
terminals (fig 5.3).  Astrocytes located in the stratum oriens of 
the CA1 area of the hippocampus respond to the stimulation 
of the alveus (which contains glutamatergic and cholinergic 
axons) with Ca2+ elevations that are specifically mediated by 
acetylcholine (ACh) but not by glutamate16.  
 
Fig 5.3 Astrocytes integrate synaptic information.  
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(a) Schematic drawing and pseudocolor images of astrocyte Ca2+ 
elevations evoked by stimulation of Schaffer collaterals (SC, red) or alveus 
(green). Astrocytes integrate synaptic information from different synaptic 
inputs. Scale bar: 15 um.  
 
(b) Hypothesis of astrocyte integration of synaptic information 
induced by SC and alveus activity (top) and astrocyte Ca2+ signals evoked 
by independent and simultaneous stimulation of SC and alveus (bottom). 
Blue and black traces correspond to the observed and expected responses 
(i.e. the linear summation of the responses evoked by independent 
stimulation of both pathways), respectively. Horizontal lines at the bottom 
of each trace represent the stimuli. Note the lack of correspondence between 
observed and expected responses, that is, the relative reduction of the 
observed response versus the linear summation of the responses evoked 
independently, which is indicative of synaptic integration.  
 
(c) Top, fluorescence images showing astrocytic Ca2+ signals evoked 
after electrical stimulation (responding cells are displayed in white) of two 
contiguous barrel cortex. Bottom, images showing an overlay of the bright-
field image with the location of the stimulating pipette and the responding 
astrocytes (shown in black). Dotted white lines outline the barrels in layer 
4. Scale bar: 100 um. Note that astrocytes that respond to the 
stimulation of the barrel column are located within the stimulated barrel 
column, and no astrocytes respond to the stimulation of the adjacent barrel 
column, which indicates the selectivity of astrocyte responses.  
 
(d) Schematic drawing illustrating the discrimination and response 
selectivity of barrel cortex astrocytes to neuronal activity from layer IV but 
not from layer II/III of neighbouring barrels. From Schipke, C.G. et al., 
2008. 
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By contrast, these astrocytes do respond to glutamate 
when it is released by different glutamatergic synapses, that is, 
the Schaffer collateral (SC) synaptic terminals25. Hence, 
astrocytes selectively respond to different synapses that use 
different neurotransmitters (i.e. glutamate and ACh), and they 
discriminate between the activity of different pathways that use 
the same neurotransmitter (i.e. glutamatergic axons of SC and 
alveus)25. Likewise, astrocytes in the ventrobasal thalamus 
respond to the stimulation of either sensory or corticothalamic 
pathways, but very few respond to the activity of both38. 
Furthermore, astrocytes in the barrel cortex also respond 
selectively to the activity of different neuronal inputs, because 
astrocytes in layer 2/3 respond to glutamatergic inputs from 
layer 4 in the same column but not to glutamatergic 
projections from layer 2/3 of adjacent columns39 (fig 5.3). 
Therefore, astrocytes show selective responses that 
discriminate the activity of specific synapses. 
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5.7 Astrocyte Ca2+ signals show a nonlinear 
relationship with the synaptic activity 
 
The analysis of the astrocyte Ca2+ signal evoked by the 
activity of different synaptic terminals that release ACh and 
glutamate indicates that astrocytes integrate synaptic 
information25. In hippocampal slices, the simultaneous 
stimulation of alveus and SC (that elicit Ca2+ elevations 
mediated by ACh and glutamate, respectively) evokes 
astrocytic responses that are inconsistent with a linear readout 
of the synaptic activity. The amplitude of the Ca2+ elevations 
elicited by simultaneous stimulation of both pathways is not 
equivalent to the linear summation of the Ca2+ signals evoked 
by independent stimulation25 (fig 5.3). Therefore, the astrocyte 
Ca2+ signal is nonlinearly modulated by the simultaneous 
activity of cholinergic and glutamatergic synapses. Moreover, 
while the Ca2+ signal evoked by simultaneous stimulation at 
high frequencies (30 and 50 Hz) displays a sublinear 
summation of the responses evoked independently, it shows a 
supralinear summation after stimulation at relatively low 
frequencies (1 and 10 Hz); that is, the Ca2+ signal is relatively 
depressed or potentiated at relative high and low frequencies 
of neuronal activity, respectively. Therefore, the astrocyte Ca2+ 
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signal is nonlinearly modulated by the simultaneous activity of 
different synaptic inputs, and the sign of this modulation 
depends on the synaptic activity level25. 
 
 
5.8 Gliotransmission and modulation of synaptic 
transmission 
 
One of the most stimulating topics in current 
neuroscience is the functional consequences of the astrocyte 
Ca2+ signal on neuronal physiology. Evidence obtained during 
the past 20 years has demonstrated that signalling between 
neurons and astrocytes is a reciprocal communication, where 
astrocytes not only respond to neuronal activity but also 
actively regulate neuronal and synaptic activity. Therefore, 
according to the concept of the tripartite synapse, to fully 
understand synaptic function, astrocytes must be considered as 
integral components of synapses where they have crucial roles 
in synaptic physiology. 
Astrocytes release several neuroactive molecules, such as 
glutamate, D-serine, ATP, adenosine, GABA, tumor necrosis 
factor a (TNFa), prostaglandins, proteins and peptides, that 
can influence neuronal and synaptic physiology3. The 
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mechanisms and consequences of this process, called 
gliotransmission, have attracted considerable interest. Several 
mechanisms of transmitter release from astrocytes have been 
proposed.  
Compelling evidence demonstrates that some 
transmitters are released in a Ca2+-dependent manner10,43–48 
through vesicle47–51 and lysosome52–54 exocytosis. Furthermore, 
ultrastructural studies have shown that astrocytic processes 
contain small synaptic-like vesicles, which are located in close 
proximity to synapses, apposed either to presynaptic and 
postsynaptic elements 49,59.  
 
Alternative release mechanisms, including reversal of 
glutamate transporters, connexin/pannexin hemichannels, 
pore-forming P2X7 receptors and swelling-induced activation 
of volume-regulated anion channels, have also been 
proposed55. Whether Ca2+-dependent and -independent 
mechanisms coexist and under what physiological or 
pathological conditions they occur remain unclear. 
The original demonstration of astrocyte-induced 
neuromodulation in cultured cells43,44,56 has been considerably 
expanded by later studies on acute brain slices. 
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Glutamate was one of the first gliotransmitters released 
from astrocytes to be identified and has been reported to exert 
many effects on neuronal excitability. Astrocytic glutamate 
evokes slow inward currents (SICs) through activation of 
postsynaptic N-methyl-D-aspartate (NMDA) receptors25,44,60–65 
and synchronously excites clusters of hippocampal pyramidal 
neurons, indicating that gliotransmission increases neuronal 
excitability and operates as a nonsynaptic mechanism for 
neuronal synchronization60,62. By contrast, astrocytic glutamate 
might also activate receptors localized at presynaptic terminals. 
Through activation of group I metabotropic glutamate 
receptors (mGluRs)46,26 or NMDA receptors50, astrocytes 
enhance the frequency of spontaneous and evoked excitatory 
synaptic currents. 
Alternatively, astrocytes induce the potentiation20 or 
depression of inhibitory synaptic transmission by activation of 
presynaptic kainate66 or II/III mGlu67 receptors, respectively.  
Therefore, a single gliotransmitter can exert multiple 
effects depending on the sites of action and the activated 
receptor subtypes, which provides a high degree of complexity 
to astrocyte–neuron communication. This complexity 
becomes even higher when considering that other 
gliotransmitters, such as GABA, ATP, adenosine (a metabolic 
product of ATP) or D-serine, could act on the same neuron or 
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act on different cell types, thus evoking distinctive 
responses63,68–72. Moreover, in hippocampal astrocytes, Ca2+ 
elevations induced by activation of PAR-1 receptors, but not 
P2Y1 receptors, evoke NMDA receptor-mediated SICs in 
pyramidal neurons65, indicating that the Ca2+ signal evoked by 
activation of different receptors might not be equally 
competent to stimulate gliotransmitter release.  
A great effort has been made so far to identify different 
gliotransmitters and their potential modulatory actions, but it 
remains unknown whether different gliotransmitters are co-
released or whether different gliotransmitters are released by 
different astrocytes or by different astrocytic processes or 
domains. It is also crucial to elucidate the specific incoming 
inputs, the molecular mechanisms and the physiological 
conditions that govern the precise release of each 
gliotransmitter. 
Intracellular regulatory mechanisms of release and 
spatially defined specific intercellular signalling pathways seem 
to be present to grant a coherent astrocyte–neuron 
communication. 
Besides glutamate, ATP and its product adenosine of 
astrocytic origin also control synaptic transmission68–71.  
Indeed, heterosynaptic depression of hippocampal 
synaptic transmission requires astrocyte release of 
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ATP/adenosine69–71, which is stimulated by the GABAB 
mediated astrocyte Ca2+ signal elicited by interneuron activity 
evoked by SC70.  
This represents a paradigmatic example of the consequences 
of coordinated neuron–glia networks on synaptic function. 
Furthermore, it also shows that synaptically evoked astrocytic 
ATP might signal to other synapses, thus spreading neuronal 
information beyond activated synapses.  
Likewise, glutamate from astrocytes stimulated by 
endocannabinoid released during neuronal activity could signal 
to adjacent unconnected neurons64, suggesting that astrocytes 
serve as a bridge for non-synaptic communication between 
neurons.  
In conclusion, astrocytes not only influence the active 
synapses through short-range signalling, but they might also 
have long-range effects on distant synapses.  
Hippocampal slices are a useful experimental model to 
study synaptic transmission, and consequently they have been 
also widely used to analyse the astrocyte effects on synaptic 
transmission. Although a comprehensive characterization of 
the phenomenon in different brain areas is still lacking, glia-
mediated synaptic transmission modulation has also been 
documented in retina, supraoptic nucleus and cerebellum, as 
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well as at the neuromuscular junction in the peripheral nervous 
system58,73.  
Finally, the effects of the activity of single astrocytes on 
single synapses have been investigated extensively in the 
hippocampus, also by performing paired recordings from 
pyramidal neurons and single astrocytes while stimulating SC 
single synapses, that is, by experimentally isolating the tripartite 
synapse46.  
 
Astrocyte Ca2+ elevations transiently increase the 
probability of neurotransmitter release from presynaptic 
terminals, thus enhancing the synaptic efficacy (fig 5.4).  
This effect is mediated by Ca2+ and SNARE protein-
dependent release of glutamate from astrocytes, which 














Fig 5.4 Astrocytes control synaptic transmission and plasticity at 
the tripartite synapse.  
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(a) Schematic drawing showing recordings from one pyramidal 
neuron and one astrocyte, and the stimulation of a single synapse.  
 
(b) Astrocyte Ca2+ levels (top) and synaptic responses (bottom) 
before and after Ca2+ uncaging at a single astrocyte. Note the increase in 
the proportion of successful synaptic responses after astrocyte Ca2+ 
elevation.  
 
(c) Astrocytes potentiate synaptic efficacy (i.e. mean amplitude of 
all responses including failures), increasing the probability of transmitter 
release (Pr: ratio between the number of successes versus the total number 
of stimuli) without modulating the amplitude of synaptic responses (i.e. 
synaptic potency, defined as mean amplitude of the successful responses). 
Note the transient increase of synaptic efficacy and Pr after elevating 
astrocyte Ca2+ (at time zero).  
 
(d,e) Temporal coincidence of astrocyte Ca2+ signal and 
postsynaptic neuronal depolarization induces long-term potentiation 
(LTP) of synaptic transmission. Excitatory synaptic currents before and 
60 min after transiently pairing neuronal depolarization and astrocyte 
Ca2+ uncaging.  
 
(f) Graphs showing relative change in synaptic efficacy, Pr and 
synaptic potency parameters over time. Arrows indicate pairing of astrocyte 
Ca2+ signal and mild neuronal depolarization. Note the persistent 
potentiation of synaptic efficacy and Pr induced by the transient pairing 
(for 5 min) of neuronal and astrocyte stimulation (at time zero).  
From Perea et al., 2007. 
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5.9 Astrocytes and synaptic plasticity 
 
Astrocytes operate at lower time scales than synaptic 
neurotransmission. Whereas fast neurotransmission occurs in 
milliseconds, astrocytic effects on neuronal physiology last 
seconds or tens of seconds. In addition, astrocyte regulation of 
synaptic transmission runs on different time scales, because 
astrocytes can control transiently the synaptic strength (during 
seconds), and they can also contribute to long-term synaptic 
plasticity. Several mechanisms underlying the astrocyte effects 
on long-term potentiation (LTP) have been described.  
Some studies indicate a passive or tonic mode of action, 
in which astrocytes tonically suppress or potentiate synaptic 
transmission69,72,74,75. Astrocytes through ATP/adenosine 
release control the strength of the basal hippocampal synaptic 
activity by tonic suppression of neurotransmission, which 
results in an increase in the dynamic range for LTP69. In the 
hypothalamic supraoptic nucleus, changes in the astrocytic 
coverage of synapses influence NMDA-receptor-mediated 
synaptic responses due to changes in the ambient levels of D-
serine released by astrocytes72. 
By contrast, astrocytes participate in the generation of 
LTP through a phasic signaling process, in which the temporal 
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coincidence of the astrocyte Ca2+ signal and the postsynaptic 
neuronal activity induces LTP through the activation of 
presynaptic type I mGluRs by Ca2+-dependent glutamate 
release from astrocytes46. These findings have expanded our 
traditional vision of the Hebbian LTP (a paradigm of synaptic 
plasticity based on the coincident activity of pre and 
postsynaptic neuronal elements) to include astrocytes as new 
sources of cellular signals involved in synaptic plasticity. 
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5.10 Are all synapses tripartite? 
 
Experiments designed to observe the effects of the 
astrocyte Ca2+ signal on single hippocampal synapses showed 
that not all recorded synapses displayed modulation of the 
synaptic efficacy after astrocyte stimulation, but only a subset 
of synapses (around 40%) underwent astrocyte induced 
potentiation46. Experimental conditions might account for 
some ineffective cases because, owing to the limits of optical 
resolution, it could not be excluded that the stimulated 
astrocyte was not in sufficient close proximity to the recorded 
synapse. Alternatively, it is feasible that, in some cases, the 
stimulated astrocyte and the recorded synapse were not 
functionally connected.  
Whether this absence of connectivity is due to functional 
or structural bases is unknown, but it is interesting to note that 
ultrastructural data shows that only a subset of hippocampal 
excitatory synapses (again around 40%) are covered by 
astrocytic processes78, which is consistent with the hypothesis 
that not all synapses are functionally tripartite. 
The fact that Ca2+ elevations evoked in a large 
population of astrocytes by ATP application potentiated 
neurotransmission in around 40% of the recorded synapses 
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further supports this hypothesis46. If this is the case, it would 
be interesting to test whether tripartite synapses are stable or 
dynamic functional units. The latter idea seems to be favoured 
by the observation that coordinated structural changes in 
astrocytic processes and synaptic spines occur in hippocampal 
synapses79 and in the somatosensory cortex where whiskers 
stimulation evokes morphological changes on astrocytic 
processes that cover synapses80.  
The plasticity in the establishment of tripartite synapses 
might have a strong impact on the function of the neuron–glia 
network. In any case, the fact that only a subset of synapses 
were effectively modulated by single astrocytes indicates that 
neuromodulation does not result from a wide spillover of the 
gliotransmitter but, instead, suggests the existence of specific 
signalling pathways between astrocytes and neurons, probably 

































Pluripotent stem cells that the researchers used to produce astrocytic cells.  
Credit: KTH, The Royal Institute of Technology. 
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here are few and precise questions at the 
basis of my thesis. My experimental work 
started, at the beginning, from confocal 
morphological observations in AD11 mice (an AD-like mouse 
model characterized by a chronical deprivation of NGF, see 
introduction). Incredibly clear – and promising – alterations 
(shrinkage of spatial coverage and loss of cellular complexity) 
in morphology of astrocytes in AD11 mice at 2 month of age, 
i.e. still in a context of relatively healthy neurons, led to a 
complex journey through the glia-neuron relationship with the 
T 
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aim of unveiling a new mechanism at the basis of 
neurodegeneration, and the consequence of wide the NGF 
therapeutic potential in neurodegeneration.  
 
The questions that animated my work and that progressively 
led the journey are formulated below. I formulated the answer 
reported after each question, through the experimental work 
progressively described in the following paragraphs.   
 
What happens to astrocytes morphology when NGF is starved? 
The astrocytes in AD11 mice are clearly atrophic; 
they show a marked shrinkage at 2 months of age i.e. in 
an early pre-symptomatic phase of this mouse model 
when other Alzheimer’s-like neurodegeneration or 
phenotypic hallmarks are not still presents in these 
animals.  
 
What are the crucial events at the basis of these morphological 
alterations? 
I suggest that the crucial event that determines 
these morphological alterations is the relative balance 
between the immature and mature form of NGF, not the 
absolute levels of each form of the neurotrophin. 
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Can we reproduce the changed astrocyte morphology in vitro?  
I demonstrated that in vivo, as well as in vitro, there 
is a correlation between the morphological complexity of 
the astrocytes and the availability of mature NGF. 
 
How do I explain the effect of the anti-NGF antibody? What 
about NGF receptors on astrocytes in vivo? 
i) Both NGF receptors are present in cultured 
astrocytes;  
ii) the receptors are located on the membrane 
surface; 
iii) they have the expected molecular weight and 
iv) cultured astrocytes produce NGF and secrete it 
in the medium. 
 
What are the genes modulated in the early phases? 
I found that specific genes identifying a reactive 
state of astrocytes were upregulated in αD11-treated 
astrocytes. Genes related to inflammation such as 
chemokines and receptors for immunoglobulins were 
individually upregulated up to 10-fold. In particular, 
kallikrein 6 (KLK6), a trypsin-like serine protease, has 
been found to be the top upregulated gene. 
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What are the short-term effects of anti NGF treatment?   
I demonstrated that, in the astrocytes, NGF 
deprivation by anti NGF antibodies causes a fast and 
durable calcium response within 5 minutes.  On the 
contrary, astrocytes are completely deaf to NGF, despite 
the fact that cultured astrocytes express both TrkA and 
p75NTR receptors. 
 This surprising striking result shows that cultured 
astrocytes can respond very rapidly to an acute reduction 
of the NGF levels, but not to an acute increase of NGF 
levels. 
 
What is the source of the calcium ions involved in the oscillations 
induced by acute anti NGF treatment? 
I demonstrated that the calcium ions involved in the 
oscillations induced by NGF deprivation derive from 
intracellular Calcium stores located in the ER. 
 
What is the trigger of the calcium oscillations induced by acute anti 
NGF treatment? 
I concluded that aD11 anti-NGF antibodies induce 
calcium oscillation via the activation of TrkA receptors. 
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What are the transcriptomic changes affecting the astrocytes at 
different times after anti-NGF antibody administration? 
The RNA modulation occurring 24 hours after the 
exposure to the αD11 anti-NGF antibody was consistent 
with a pan-reactive phenotype and, in particular, with the 
acquisition of a full A1-like neurotoxic phenotype. 
 
What happens to neurons, in astrocytes-neuron co-cultures, when 
astrocytes react to NGF starvation? 
I demonstrated that the NGF neutralization leads to 
death hippocampal neurons, but only if the neurons are 
co-cultured with astrocytes. 
 
What are the possible mechanisms that couple astrocytes and 
neuron impairment? 
The neuronal impairment induced by anti NGF 
antibodies, is reduced by: 
i) the concomitant neutralization of the amyloid 
β oligomers with the specific anti- Aβ-
oligomer A13 antibody, or by  
ii) the concomitant g lutamate ionotropic 
receptors blockade.  
This indicates that the effects of deprivation of NGF might 
imply the production of β amyloid oligomers or 





Does the astrocyte Ca2+ elevations induced by NGF starvation 
might trigger Ca2+ hyper-activation in neurons? 
I demonstrated that the fast increase in the 
astrocytes Ca2+ oscillations that follows the NGF 
neutralization is mediated by the TrkA and leads to an 
alteration in neuronal Ca2+ activity, leading neuron to 
death. 
 
Can this atrophy in the brain of 3xTG-AD mice be reverted by 
the administration of NGF? 
The results demonstrate that the astrocytes atrophy 
can be reverted by NGF nasally administered. I found the 
same results with both AD11 and 3xTg-AD mice. 
 
Can NGF levels modulate astrocyte calcium activity also in vivo, 
in anesthetized animals? And in awake behaving animal? 
We discovered that, also in vivo, while NGF exerted 
no effect on astrocytic Calcium activity, a lack of the 
neurotrophin by anti NGF induction increased astrocyte 
calcium activity in the anesthetized mouse as well as in 
the awake behaving animal. 
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What are the early events after an acute NGF starvation? Does 
the astrocyte react to acute NGF deprivation also translating new NGF 
protein? 
An NGF pulse clearly appears after only 5 minutes 
from acute NGF starvation by αD11 antibody.  
I demonstrated that the NGF pulse is new 
synthetized protein, i.e. not an amount previously stored 
in intracellular compartments. 
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6.1 NGF deprivation induces morphological 
alterations of astrocytes in vivo 
 
What happens to astrocytes morphology when NGF is starved? 
 
 In order to investigate the relationship between NGF 
and the phenotype of astrocytes, I exploited the AD11 mouse 
model.  
As described in the Introduction, the AD11 mice 
develop a progressive and comprehensive neurodegeneration, 
triggered by a proNGF/NGF imbalance caused by the 
expression of an antibody that blocks mature NGF but binds 
with 2000-fold less affinity to the proNGF precursor.  
At the basis of my work, I started measuring the 
morphology of astrocytes from different mouse models in 
order to address the question if astrocytes could modify their 
morphology in reaction of NGF level modulation.  
I analysed the astrocyte morphology in the hippocampus 
of AD11 or wild type (wt) mice of different ages, when the 
majority (ca. 80%) of astrocytes express GFAP. I evaluated 
four astrocyte morphological parameters: volume and area of 
the cells, the length of the processes and the number of 
branching points.  
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All measurements were performed on anti-GFAP 
labelled astrocytes in 40 μm hippocampal slices (fig 6.1 a). 
 
I repeated the measures at 1, 2, 3, 6 and 12 months of 
age and found that in AD11 mice, compared to controls, there 
is a strong reduction of all the parameters at 2 months. These 
alterations persist (length, branching points), slightly reduce 
(area) or regress (volume) at 6 months. In between 6 and 12 
months of age, an inversion of the trend was present. I found, 
definitely in 12 months old animals, that the wild type (wt) 
astrocytes show a reduction of all four morphological 
parameters values. This trend inversion is probably due to an 
astrogliosis caused by the aging and the conclamant 
Alzheimer-like phenotype in AD11 mice22,35,36. Moreover, in 
every group of mice the complexity of the astrocytes 
morphology tends to reduce with the time. 
Immunohistochemistry (IHC) was repeated also with 
anti-S100 β, to verify whether the actual structure of the 
astrocytes, and not only their GFAP amount, was really 
changed.  
S100 calcium-binding protein β (S100 β) is a protein of 
the S-100 protein family. S100 proteins are localized in the 
cytoplasm and nucleus of a wide range of cells and involved in 
the regulation of several cellular processes such as cell cycle 
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progression and differentiation. S100 β is glial-specific and is 
expressed primarily by astrocytes.  
With S100 β immunochemistry I found the same 
modifications observed with GFAP, with the only difference 
that the reduction of the area was not statistically significant. 
This is probably due to the fact that the anti-GFAP antibody 
does not label the cell body as the anti-S100B antibody does. 
 IHC against S100 β were performed in AD11 and wt 
animals of 2 months of age (fig 6.1 b). 
The collected evidence leads to conclude that the 
morphological changes observed in astrocytes are really due to 
a structural change of these cells and could not be explained by 
a fluctuation of cell marker expression.  
 
To further confirm the data, I used another staining 
technique: the silver impregnation according to Golgi-COX 
methods, that allows to visualize astrocytes independently 
from the use of antibodies against cytoskeletal proteins.  
I found comparable results (fig 6.3) with what observed 
with IHC.    
 
The astrocytes in AD11 mice are clearly atrophic; 
they show a marked shrinkage at 2 months of age i.e. in 
an early pre-symptomatic phase of this mouse model 
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when other Alzheimer’s-like neurodegeneration or 
phenotypic hallmarks are not still presents in these 
animals.  
 





















Fig 6.1- A1 - NGF deprivation induces morphological alterations 
of astrocytes in vivo.  
AD11 are compared with WT, marked with GFAP antibody. 
All measurements were performed on anti-GFAP labelled astrocytes in 
40 μm hippocampal slices. Here is reported the 2 months of a. 
experiment. 
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Fig 6.1- A2 - NGF deprivation induces morphological alterations 
of astrocytes in vivo.  
AD11 are compared with WT, marked with GFAP antibody.  
Quantification of the previous. 




























Fig 6.1- B1 - NGF deprivation induces morphological alterations 
of astrocytes in vivo.  
AD11 are compared with WT, marked with S100B antibody. 
Mice: 2 m. of age. 
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Fig 6.1- B2 - deprivation induces morphological alterations of 
astrocytes in vivo.  
AD11 are compared with WT, marked with S100B antibody. 
Quantification of the previous. 




At this step it is clear that, in this anti-NGF mouse model, an 
astrocyte impairment is precociously present.  
In this model, the neutralization of NGF by the transgenic 
antibody leads to variable amounts of captured NGF in different 
mice and, therefore, to variable amounts of free NGF.  I 
measured the amounts of free NGF (see Methods) in the brains 
of individual mice and correlated this parameter with astrocyte 
morphology parameters.  
 
The astrocyte atrophy well correlates with the free NGF 
levels (fig 6.2). 
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Fig 6.2 - part 1 of 2.  
The atrophy well correlates with the free NGF level.  
Here are reported the correlations with area and length of 
astrocytes. See M&M for details.  
 
 







Fig 6.2 - part 2 of 2.  
The atrophy well correlates with the free NGF level.  
Here are reported the correlations with volume and number of 
branching points of astrocytes. See M&M for details. 
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Fig 6.3 - The dysmorphic astrocyte morphology is measured also with 
Golgi-COX staining technique.  
Pictures at left - A: Wt mice, B: AD11 mice, both of 2 months of 
age. 
Histogram at right - quantification of astrocyte area: Wt vs 
AD11 mice. 




6.2 Mechanism(s) at the basis of astrocytes altered 
morphology: role of proNGF  
 
What are the crucial events at the basis of these morphological 
alterations? 
 
In the introduction, I described the characteristics of the 
αD11 antibody and in particular the fact that at certain 
concentrations it recognizes and neutralizes in a specific 
manner the mature form of NGF, and not the pro-
neurodegenerative precursor proNGF (Corvaglia et al., 2019).  
Indeed, the affinity of αD11 anti NGF for mature NGF 
is 2000-fold higher than its binding affinity for proNGF (data 
from A. Cattaneo’s lab). 
This led to postulate that the experimental imbalance of 
proNGF versus NGF is responsible for the observed 
morphological change in AD11 mice.  
In order to test this hypothesis with a different 
experimental manipulation, I postulated that also an over-
expression of proNGF might contribute to the asthenic 
phenotype of astrocytes. To test this, I studied the 
morphology of astrocytes in mice over-expressing a proNGF 
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in a form which is uncleavable at the furin site (Tiveron et al., 
2013). 
These mice accumulate proNGF in the brain. In these 
animals I performed the same GFAP IHC previously 
described for AD11 mice, followed by image analysis of the 
cell phenotype for the 4 morphological parameters considered 
above. 
In proNGF mice (formally TgproNGF#3 mice, see 
Tiveron et al., 2013) I found a more evident morphological 
alteration than that  found in AD11 mice, described by the 
decrease of Area, Volume, number of Branching Points and 
Length of the astrocyte filaments in a statistically significant 
way, both with  respect to AD11 and to control mice (see 
M&M for details, and fig 6.4). 
 We thus observed a similar change of astrocyte 
morphology by experimentally manipulating the proNGF and 
NGF levels in two different ways, either selectively interfering 
with mature NGF (in AD11 mice) or increasing the levels of 
proNGF (in the TgproNGF#3 mice).  
 
For this reason, I suggest that the crucial event that 
determines these morphological alterations is the relative 
balance between the immature and mature form of NGF, 
not the absolute levels of each form of the neurotrophin.




























Fig 6.4 - proNGF (formally TgproNGF#3) mice shows a more 
evident morphological alteration than the one found in AD11 mice.  
The age of both AD11 and proNGF mice was 2 months. See 
M&M for details.   
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6.3 In vitro effects of NGF depletion 
 
Can we reproduce the changed astrocyte morphology in vitro?  
 
To better understand the relationship between NGF and 
the changes in cellular morphology, I cultured astrocytes from 
P4 wild type mice, and I treated them in vitro with NGF or 
αD11 anti-NGF antibodies. The cells were evaluated at DIV28 
after different treatments for 48 hours with or without NGF 
(100ng/ml) and, in sister cultures, with αD11 anti-NGF 
antibody or anti-V5 as a control-antibody at increasing 
concentrations. We previously developed a mathematical 
model that describes the interactions between NGF, proNGF 
and αD11 anti-NGF antibodies to choose 3 different αD11 
concentrations in order to progressively neutralize NGF and 
not proNGF or both (Corvaglia et al., 2019).  
I performed a Sholl test to evaluate the morphology. 
The results, quantified in fig 6.5 a, showed that the astrocytes 
complexity is unaltered with anti-V5 (see above, used as a 
control for antibody presence), NGF or low αD11 exposition 
(100 ng/ml). The number of filaments from the cell body to 
the periphery decreases if αD11 is added at a mild 
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concentration (200 ng/ml), and dramatically reduces with high 
concentrations (400 and 800 ng/ml).  
 
The progressive and complete depletion of neurotrophin 
causes important changes in morphology in these cells and, on 
the other hand, no changes occur when NGF is added in vitro 
(fig 6.5 panel 1). 
 
In conclusion, I demonstrated that, in vivo as well 
as in vitro, there are strong elements to assess a 
correlation between the morphological complexity of the 
astrocytes and the availability of mature NGF. 
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Fig 6.5 - panel 1 of 4. In vitro effects of NGF depletion.  
The asthenic phenotype (i.e. reduction in morphological complexity) 
of astrocytes, observed in AD11 and TgproNGF#3 mice, can be 
reproduced in vitro, by incubation with anti NGF antibodies. Fluorescent 
microscope images of GFAP immunoreactive astrocytes after the treatment 









Fig 6.5 – panel 2 of 4. In vitro effects of NGF depletion.  
Quantification of the previous. 
Astrocyte labelled with GFAP antibody are treated with different 
αD11 anti-NGF antibodies and their morphology is measured with a 
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Fig 6.5 - panel 3 of 4. In vitro effects of NGF depletion 
Expression of P75NTR and TrkA on cultured GFAP+ 
astrocytes. MNAC13: Astrocytes are labelled against TrkA using also 






























Fig 6.5 - panel 4 of 4. In vitro effects of NGF depletion 
 (a) FACS analysis to isolate cells expressing both GFAP and 
NGF receptors  
(b) Western blot showing the expression of p75NTR and TrkA 
in three independent samples  
(c) Quantification of the amount of NGF secreted in astrocytic 
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6.4 Astrocytes express NGF receptors in vitro 
 
How do I explain the effect of the anti-NGF antibody?  
 
The presence of NGF high affinity (NTRK1) and low 
affinity (p75NTR) receptors on the astrocytes in vivo and in vitro is 
still debated39,40. Here I demonstrate that they are both 
expressed in cultured astrocytes using different techniques (fig 
6.5). 
First of all, I found that p75NTR and TrkA are both 
expressed on the membrane of cultured astrocytes, since the 
immunoreactivity was found by performing detergent-free 
IHC, i.e. without permeabilizing the membrane. In this 
experiment, to detect TrkA, I used a polyclonal commercial 
antibody and the monoclonal antibody MNAC13 41,42 and I 
obtained the same result.  The anti TrkA mAb MNAC13 has 
been produced in the lab and has been validated on sections 
from TrkA-/- knockout mice. 
To confirm these data, I was able to sort by FACS 
astrocytes labelled with anti-p75 and MNAC13 antibodies 
detecting, respectively, an enrichment of 75.17% and 86.32% 
in the GFAP+ fraction (fig 6.5 a). I also performed SDS-
PAGE WB for the two receptors, in order to verify their 
correct molecular weight.  As reported in the fig 6.5 b, I found 
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that both p75NTR and TrkA are present at the expected 
molecular weight of, respectively, 75 KDa and 120 KDa.  
 
In addition to the receptors, I demonstrated the 
capability of cultured astrocytes to produce NGF, by 
measuring the progressive NGF accumulation in the culture 
medium with an ELISA test (fig 6.5 c). 
 
All these findings, taken together, demonstrates 
that:  
i)  both NGF receptors are present in cultured 
astrocytes;  
ii) the receptors are located on the membrane 
surface; 
iii) they have the expected molecular weight and 
iv) cultured astrocytes produce NGF and secrete 
it in the medium . 
 
 
Taken together, all these findings demonstrate that, at 
least in vitro, astrocytes have the capability to respond directly 
to NGF/proNGF levels (i.e. not obligatorily trough the 
mediation of other cells) and, moreover, that they are capable 
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to deal and potentially interfere in an homeostatic way with the 
NGF levels. 
 
What about NGF receptors on astrocytes in vivo? 
 
Cortical astrocytes from wild-type mice do not express 
p75NTR and TrkA at detectable levels in vivo (Capsoni et al., 
2017 and 2019), but do so in culture.  
A significantly increased astrocytic p75NTR 
immunoreactivity was found in PBS-treated 5xFAD mice, 
which was decreased after human painless NGF (formally 
hNGFp; Capsoni et al., 2016 and 2017). 
The hNGFp has identical neurotrophic potency as wild-
type human nerve growth factor, but a 10-fold lower pain 
sensitizing activity treatment (Capsoni et al., 2016). 
Most importantly, also in Alzheimer’s disease brain 
sections, Capsoni and colleagues, in our lab, could detect an 
increased expression of both p75NTR and TrkA in astrocytes 
(Capsoni et al., 2017). 
 
RESULTS - NMC - SNS  
124 
 
6.5 Atrophic astrocytes induced by anti NGF 
antibody treatment display a phenotype of reactive 
astrocytes 
 
What are the genes modulated in the early phases? 
 
To further characterize the phenotype of atrophic (called 
also asthenic) astrocytes triggered by anti NGF antibodies, a 
transcriptomic analysis was performed in cultured astrocytes 
after an incubation of 8 hours with the αD11 antibody (for 
experimental details see M&M). 
 I found that specific genes identifying a 
reactive state of astrocytes were upregulated in αD11-
treated astrocytes (Table 1). Genes related to 
inflammation such as chemokines and receptors for 
immunoglobulins were individually upregulated up to 10-
fold. In particular, kallikrein 6 (KLK6) (Table 1), a 
trypsin-like serine protease, has been found to be the top 
upregulated gene.  
Interestingly, KLK6 has been reported to be upregulated 
in reactive astrocytes during injury and serve as a molecular 
trigger of select physiological processes involved in the 
development of astrogliosis (Scarisbrick et al., 2012).  
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Indeed, KLK6 is involved in the transformation of 
astrocytes from an epithelioid to a stellate morphology which 
is characteristic of reactive astrocytes, via condensation of 
cortical actin (Yoon et al., 2018). Interestingly, KLK6 increases 
intracellular calcium. This correlates with the modulation of 




Table 1: gene modulation of astrocytes after 8 hours with the 
αD11 antibody. See above and M&M for details. 
  
The upregulation of the expression of KLK6 has been 
confirmed by immunocytochemistry, in comparison to NGF 
and control antibody (V5 antibody) (Fig. 6.6). 












Fig. 6.6 (top) Immunofluorescence for Kallikrein 6 (green), a 
marker of astrocytic reactivity and (bottom) quantification. ***P<0.001. 
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6.6 The NGF depletion increases astrocyte calcium 
oscillation    
 
The results demonstrated above relate to a treatment of 
astrocytes with anti NGF of several hours (transcriptomic 
data) or days (morphological analysis).  
 
What are the short-term effects of anti NGF treatment?   
 
Prompted by the findings in the transcriptomic analysis, 
I set up to investigate the effects of NGF deprivation on the 
astrocytic calcium transients44–46. 
Each registration session consists of 1000 single frames 
acquisition taken every 5 seconds, for a total duration of 1 
hour after .ca 20 minutes of stabilization. The registration is 
conducted under still medium condition (no perfusion was 
running) due to the astrocytes mechanosensor that could 
modulate the calcium waves.  
See fig 6.7 in order to appreciate a typical experimental 
output. 




Fig 6.7 Calcium waves in astrocytes: my typical rough experimental 
output 
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After 250 frames (.ca 20 minutes) of baseline registration, 
I added anti-V5 antibody (800 ng/ml), αD11 (800 ng/ml) or 
murine NGF (100 ng/ml). The total volume in the registration 
chamber is 3 ml; the compounds were diluted in 20 µl of 
KREBS (120 mM sodium chloride, 5 mM potassium chloride, 
2 mM calcium chloride, 1 mM magnesium chloride, 25 mM 
sodium bicarbonate, and 5.5 mM D-glucose, pH 7.3, 0.22 
micron filtered) solution and slowly added in the Petri dish 
with a small tip, far from the focused registration area. 
I registered a very good and constant basal activity and 
expressed the results, due to the non-ratiometric intrinsic 
nature of the Oregon Green BAPTA-2, as the percentage of 
responding cells for each frame.  
The experiment, summarized in fig 6.8, showed that 
there was no activity change whatsoever in presence with 
NGF 100 ng/ml. On the contrary, a strong and consistent 
increase in the number of responding cells was observed with 
a αD11 anti NGF 800ng/ml treatment, not occurring after 
incubation with the control antibody anti-V5. 
I considered an active cell if the increase of the signal is 
5% higher of the average brightness of the same cell calculated 
in the previous 15 and subsequent 15 frames.   
The number of oscillating cells was about 30 cells per 
frame in the baseline, as well as in the control and NGF 
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experiments; 5 minutes after the administration of αD11 
800ng/ml (or 400ng/ml but none 200ng/ml, see fig 6.8) the 
oscillation increase in number and amplitude. 
 A typical signal profile is shown in fig 6.8 a. More than 
60 cells per frame were oscillating (fig 6.8).  
 
Thus, in conclusion, I demonstrated that, in the 
astrocytes, NGF deprivation by anti NGF antibodies 
causes a fast and durable calcium response within 5 
minutes.  On the contrary, astrocytes are completely deaf 
to NGF, despite the fact that cultured astrocytes express 
both TrkA and p75NTR receptors. 
  
This surprising striking result shows that cultured 
astrocytes can respond very rapidly to an acute reduction 
of the NGF levels that they secrete themselves, but not to 
an acute increase of NGF levels. 
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6.7 The Ca2+ involved in anti-NGF dependent 
calcium waves derives from ER-stores  
 
What is the source of the calcium ions involved in the oscillations 
induced by acute anti NGF treatment? 
 
Intracellular Calcium can increase from Calcium stores   
located in the ER (Endoplasmic Reticulum) or from the 
extracellular medium. In order to address this question, I 
pretreated the astrocytes, respectively, with thapsigargin48 (to 
block ER calcium stores) or with the Calcium chelator EGTA 
(to block extracellular Calcium and prevent it from entering 
the cell via Voltage gated Calcium Channels) before evoking 
calcium oscillations by adding anti NGF antibodies. 
First of all, I examined whether calcium responses in 
astrocytes evoked by 800 ng/ml of αD11 were affected by the 
administration of thapsigargin. To do that, I induced the 
calcium oscillation as described above; after 20 minutes I 
treated the cells with thapsigargin (1 μM) and observed that 
the increase in calcium oscillations was strongly abolished and 
the number of responding cells was comparable with the 
baseline activity (fig 6.8). 
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Moreover, the depletion of intracellular Ca2+ ions 
determined by a pretreatment with thapsigargin (1 μM) 30 min 
before the beginning of the registration did not affect the 
baseline calcium response but made the astrocytes 
unresponsive to αD11 antibody (fig 6.8).  
Under no circumstances the treatment with EGTA 
prevented or abolished the calcium oscillations, like PBS 
solvent control and V5 antibody control (data not shown).  
 
Thus, I demonstrated that the calcium ions 
involved in the oscillations induced by NGF deprivation 
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Fig 6.8 – panel 1 of 3. The NGF depletion increases astrocyte 
calcium oscillations 
The calcium oscillations of plated astrocytes are recorded and 
graphicated above. No increase in frequency or amplitude is recorded with 
NGF nor V5-control antibody administration. On the contrary, αD11 
causes a fast and durable increase. 






















Fig 6.8 – panel 2 of 3. The NGF depletion increases astrocyte 
calcium oscillations. 
(a) quantifications of previous;  
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6.8 Calcium oscillations induced by anti NGF 
antibodies are abolished if TrkA expression is 
chemogenetically inhibited in astrocytes 
 
What is the trigger of the calcium oscillations induced by acute anti 
NGF treatment? 
 
Since I demonstrated that the αD11 anti-NGF antibody is 
able to induce calcium oscillation in astrocytes, I postulated that 
the NGF secreted by astrocytes (see above) might stimulate TrkA 
receptors on astrocytes in an autocrine or a paracrine way. 
  
In order to investigate the relationship between TrkA 
NGF receptors and their effect on calcium oscillations induced by 
anti NGF antibodies, I exploited a chemogenetic approach, taking 
advantage of the Ntrk1tm1Ddg/J mice49. These mice carry a 
floxed F592A mutation in exon 12 of the mouse NTRK1 (TrkA) 
gene. The mutation in the floxed allele encodes a TrkA receptor 
that is sensitive to a family of small-molecule inhibitors, including 
1NMPP1, which acts selectively, rapidly and reversibly to inhibit 
TrkA activation49. 
I cultured the astrocytes from these TrkA inducible knock 
out mice and incubated them in the presence or absence of the 
inhibitor 1NMPP1 10 μM (fig 6.8 panel 3).  
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In the absence of 1NMPP1, the treatment with αD11 anti 
NGF induced a fast and durable increase of calcium oscillations 
in astrocytes from Ntrk1tm1Ddg/J mice, similarly to what 
happens in wt astrocytes.  
This calcium activity was completely blocked if the 
astrocytes, treated with αD11, were pre-incubated with 1NMPP1 
(see fig 6.8 panel 3).  
 
Thus, I concluded that aD11 anti-NGF antibodies 
induce calcium oscillation via the activation of TrkA 
receptors. 
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Fig 6.8 – panel 3 of 3. Calcium oscillations induced by anti 
NGF antibodies are abolished if TrkA expression is chemogenetically 
inhibited in astrocytes 
The αD11-induced calcium oscillations are also recorded in 
astrocytes from Ntrk1DG mice. When the TrkA-silencing compound 
1NMPP1is added, the αD11-induced calcium oscillations are not 
observed. 
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6.9 Transcriptomic changes at 8, 24 and 48 hours 
after anti-NGF antibody administration  
 
I described above the genes modulated after 8 hours of 
incubation with αD11. 
 
What are the transcriptomic changes affecting the astrocytes at 
different times after anti-NGF antibody administration? 
 
When I analysed the effects after 24 hours (differently 
from 8 h and 48 h) from the beginning of the incubation (for 
experimental details see M&M), I found that the changes in 
astrocyte morphology are accompanied by transcriptomic 
changes which identify a transcriptional fingerprint typical of 
reactive type A1 neurotoxic astrocytes70.  
I verified the expression of the A1 neurotoxic markers 
and of the A2 neuroprotective markers in the transcriptomic 
datasets acquired from astrocytes treated with anti NGF 
antibodies for 8, 24 and 48 hours.  I found that at 24 hours 
(but not at 8 or 48 hours) most A1-specific markers were 
upregulated in anti NGF treated astrocytes.  
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On the other side, at 24 hours (but not at 8 or 48 hours) 
most A2-specific markers were downregulated in anti NGF 
treated astrocytes.   
 
Gene:   fold at time: (ns = non-significant) 
8h                  24h  48h 
Pan reactive 
 
Lcn2    +1,16 ns +1,08  +0,1 ns  
Steap4   -  +1,58  - 
S1pr3   -0,15 ns  +0,73  -0,4 ns 
Timp1   -0,65 ns  -1,40  -0,63 ns 
Hspb1   -0,66 ns  -1,76  -0,38 ns 
Cxcl10   +0,08 ns +2,46  -0,08 ns 
Cd44   +0,02ns  -0,69  -0,25 ns 
Osmr   +0,34 ns +0,75  -0,12 ns 
Cp   +0,09 ns +1,8  -0,33 ns 
Serpina3n  +0,17 ns -0,32  -0,17 ns 
Aspg   +0,23 ns -0,89  +0,71 ns 
Vim   +0,04 ns +0,39  +0,09 ns 




H2-T23   -0,02 ns  +1,37  +0,13 ns 
Serping1  +0,15 ns +1,26  +0,21 ns 
H2-D1   +0,1 ns  +1,07  -0,1 ns 
Ggta1   -  +0,86  - 
Ligp1   -  -  - 
Gbp2   +0,11ns  +1,87  +0,09ns 
Fbln5   +0,07ns  +1,01  +0,48ns 
Ugt1a1   +0,1ns  -0,24  +0,26ns 
Fkbp5   +0,30ns  -0,25  +0,08ns 
Psmb8   -0,16ns  +1,16  +0,04ns 
Srgn   -0,12ns  +0,74  +0,04ns 
Amigo2   -0,63ns  -0,07  -0,21ns 






Clcf1   +0,14ns  -2,39  +0,04ns  
Tgm1   -  -1,06 - 
Ptx3   -  -2,11  - 
S100a10  +0,07ns  -0,96  -0.09ns 
Sphk1   -0,21ns  -1,02  +1,12  
Cd109   +0,20ns  -0,60   +0,12ns 
Ptgs2   +0,41ns  -2,64  +0,11ns 
Emp1   +0,12ns  -1,14  +0,16ns 
Slc10a6   -  -  - 
Tm4sf1   +0,01ns  +0.00  +0,1ns 
B3gnt5   -  -0,83  - 




Table 2: modulation of markers for neurotoxic and neuroprotective 
astrocyte phenotype in astrocytes after 8, 24 and 48 hours with the αD11 
anti NGF antibody. 
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As reported in table 2, the RNA modulation occurring 24 
hours after the exposure to the αD11 anti-NGF antibody 
was consistent with a pan reactive phenotype and, in 
particular, with a full A1-like neurotoxic phenotype. 
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6.10 In astrocyte-neuron co-cultures, the NGF 
starvation leads to neuronal impairment and death  
 
 
What happens to neurons, in astrocytes-neuron co-cultures, when 
astrocytes react to NGF starvation? 
 
Given the demonstration that incubation with anti NGF 
antibodies leads to the acquisition of an A1 neurotoxic 
phenotype, it seemed important to investigate how this 
important and unexpected finding could influence neuronal 
physiology.  
 
To this aim, I performed astrocytes-neurons co-cultures. 
I separately cultured astrocytes for 2 weeks and hippocampal 
neurons for 1 week, as described in the M&M section. I 
cultured the two cellular types separately to be sure to obtain a 
high grade of purity of each culture type. Of note, 
hippocampal neurons do not express TrkA receptors (Capsoni 
et al., 2017). 
 At the end of the two respective periods of culture I 
joined the two cultures, re-plating the detached astrocytes onto 
the neuronal culture with proportion between neurons and 
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astrocytes of 1:1. After a week of co-culture, the two cultures 
perfectly integrate (see fig 6.9 F) and I started the treatments. 
 
I first treated hippocampal neurons, alone or cultured 
with hippocampal astrocytes, with NGF (100 ng/ml), anti-V5 
(as a control for antibody 800ng/ml), αD11 (800 ng/ml), NGF 
followed by αD11 (NGF and then αD11, 3 days delay, 
respectively 100 ng/ml and 800 ng/ml).   
In order to evaluate the presence of possible neuronal 
degeneration, the experimental readout on the neuronal 
culture was evaluated looking at morphological alterations 
commonly found in degenerating cells63.  
Neurons were identified by MAP2 immunoreactivity and 
were considered healthy if none of the following parameters 
was met: i) degenerated soma, with or without detached 
dendrites, ii) blebbing of dendritic membrane or iii) dendrite 
degeneration and rupture.  
The percentage of healthy hippocampal neurons 
cultured alone is comparable to that for neurons co-cultured 
with astrocytes.  
In neurons co-cultured with astrocytes, incubation with 
NGF or with control anti V5 antibody determines no change. 
On the contrary, the treatments with αD11 or with NGF 
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followed by αD11, determined (after 2 days) a dramatic 
decrease of healthy neurons.  
 
I also evaluated the amount of cleaved caspase 3 in 
neurons plated with astrocytes after the treatments with NGF 
(100 ng/ml), anti V5 (800 ng/ml), αD11 (800 ng/ml), NGF 
followed by αD11 (after 3 days, respectively 100 ng/ml and 
800 ng/ml) and also treating the neurons cultured alone with 
the supernatant of astrocytes previously treated (within 24 
hours) with αD11 (800 ng/ml). In the cases of αD11 and NGF 
followed by αD11, the caspase 3 cleavage increased up to 4-
fold (fig 6.9 A).  
The results that I obtained counting the percentage of 
TUNEL+ neurons after the same treatments are 
superimposable to the ones discussed above (fig 6.9 A).  
 
This demonstrates that the NGF neutralization 
leads to a neuronal impairment, but only if the neurons 
are co-cultured with astrocytes.  
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Fig 6.9 Atrophic astrocytes becomes neuro-toxic 
Panel A.  
Top-right: Amount of cleaved caspase 3 in neurons plated with 
astrocytes after the treatments with NGF (100 ng/ml), anti V5 (800 
ng/ml), αD11 (800 ng/ml), NGF followed by αD11 (after 3 days, 
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respectively 100 ng/ml and 800 ng/ml) and also treating the neurons 
cultured alone with the supernatant of astrocytes previously treated (within 
24 hours) with αD11 (800 ng/ml).  
In the cases of αD11 and “NGF then αD11”, the caspase 3 
cleavage increased up to 4-fold). 
 
Top-right and bottom: The results depicted above are 
superimposable with the ones that I obtained counting the percentage of 
TUNEL+ neurons after the same treatments (NGF, V5, αD11, 
NGF then αD11). 
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6.11 The effects of NGF deprivation onto astrocytes 
might imply the production of β amyloid oligomers or 
glutamate excitotoxicity, impairing neurons  
 
 
What are the possible mechanisms that couple astrocytes and 
neuron impairment? 
 
I postulated that the death of hippocampal neurons co-
cultured with anti NGF-treated astrocytes might be executed 
by amyloid β oligomers, the known toxic form of the Aβ 
peptide. In order to test this hypothesis, I exploited the 
recombinant antibody fragment scFvA13, generated in the lab, 
that specifically recognizes the oligomeric forms of the Aβ 
peptide, and not Aβ monomers nor Aβ fibrils (Meli et al 
(2009) Journal of Molecular Biology).  
I also tested the hypothesis that the neuronal death 
might be due to glutamate excitotoxicity. 
To answer to these pivotal questions, I treated 
hippocampal neurons, alone or cultured with hippocampal 
astrocytes, with αD11 + A13 (a highly specific anti-β amyloid 
antibody against oligomers of this peptide, respectively 800 
ng/ml and 1:300 dilution) and with αD11 + kynurenic acid 
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(KynA, antagonist of the glutamate ionotropic excitatory 
amino acid receptors, respectively 800 ng/ml and 50 μM). Fig 
6.9 B and C. 
 
The results of this experiment demonstrated that 
the neuronal impairment is reduced when NGF is 
neutralized concomitantly with the amyloid β 
neutralization with A1362 or concomitantly with the 
glutamate ionotropic receptors blockade (fig  6.9 B and 
C), thus indicating that the effects of deprivation of NGF 
might imply the production of β amyloid oligomers and 
excitotoxicity.  
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Fig 6.9 Atrophic astrocytes becomes neuro-toxic 
Panel B. 
The percentage and morphology of healthy neurons cultured alone is 
comparable to the one calculated for neurons co-cultured with naïve 
astrocytes (bottom). In neurons co-cultured with astrocytes, the treatments 
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with αD11 determined (after 2 days) a dramatic decrease of healthy 
neurons. This effect was reduced adding also KynA. 
                                                                                                  RESULTS - NMC - SNS 
 
 

























Fig 6.9 Atrophic astrocytes becomes neuro-toxic 
Panel C. 
In neurons co-cultured with astrocytes, the treatments with αD11 
and NGF followed by αD11, but none NGF alone or anti-V5, 
determined (after 2 days) a dramatic decrease of healthy neurons. This 
effect was reduced when αD11 was co-incubated with A13 or KynA. 
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6.12 The astrocyte Ca2+ elevations induced by NGF 
starvation trigger Ca2+ hyper-activation in neurons 
 
It is well demonstrated that a cooperation between 
astrocytes and neurons is a prerequisite to support ictal 
(seizure-like) and interictal epileptiform events64. 
During these events, neurons engage astrocytes in a 
recurrent excitatory loop, possibly involving gliotransmission, 
that promotes seizure ignition and sustains the ictal discharge65 
and, possibly, neuronal death. 
 
Does the astrocyte Ca2+ elevations induced by NGF starvation 
might trigger the observed Ca2+ hyper-activation in neurons? 
 
For this purpose, I treated neuronal-astrocytes co-
culture with αD11 (800 ng/ml) of anti V5 (800 ng/ml), and I 
measured the average number of Ca2+ oscillations after 400 
seconds of each treatment.  
The experimental plane and the results are summarized 
in fig 6.9 D-E. I measured a statistically significant increase in 
the Ca2+ transient average number after the αD11 
administration. I also co-cultured wilt type neurons with TrkA 
KO-inducible astrocytes from Ntrk1tm1Ddg/J mice and 
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observed that the increase in Ca2+ transients was prevented by 
the 1NMPP1 treatment.  
This compound, given concomitantly with αD11 in wt 
neuron / wt astrocytes, did not impair the αD11 effects. 
 
These results demonstrate that the fast increase in 
the astrocytes Ca2+ oscillations that follows the NGF 
neutralization is mediated by the TrkA and leads to an 
alteration in neuronal Ca2+ activity and leads neuronal 
death. 
  







Fig 6.9 Atrophic astrocytes becomes neuro-toxic 
Panel D. 
Left: I treated neuronal-astrocytes co-culture with αD11 (800 
ng/ml) of anti V5 (800 ng/ml), and I measured the average number of 
Ca2+ after 400 seconds of each treatment.  
I measured a statistically significant increase in the Ca2+ transient 
average number after the αD11 administration. Neither co-culture treated 
with saline nor the ones treated with V5 differ from normal calcium 
behavior. TTX completely abolishes the calcium waves as expected. 
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Right: I also co-cultured wt neurons with TrkA KO-inducible 
astrocytes from Ntrk1tm1Ddg/J mice and observed that the increase in 
Ca2+ transients was prevented by the 1NMPP1 treatment.  
This compound, given concomitantly with αD11 in wt-neuron/wt-
astrocytes, did not impair the αD11 effects. 




















Fig 6.9 Atrophic astrocytes becomes neuro-toxic 
Panel E. 
Here is reported a typical calcium waves experiment frame. At t1, 
saline solution did not cause any change; at t2, calcium waves strongly 
increased when αD11 was added. As washout and internal control, TTX 
immediately abolishes the trace (t3). 
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Fig 6.9 Atrophic astrocytes becomes neuro-toxic 
Panel F. 
Images from neuron-astrocyte co-coltures. The bottom picture is the 
magnification of the widest one above circumscribed within the dotted 
square. The integration among the two populations was strong and 
neurons - astrocytes showed synaptic integration areas (naïve untreated). 
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6.13 In vivo rescue of astrocytes atrophy by NGF in 
different AD models  
 
 
The initial experimental observation that triggered this 
PhD thesis was a description of the in vivo asthenic phenotype 
of astrocytes in the hippocampus of AD11 and TgproNGF#3 
mice (fig 6.1 and 6.4). In those models that phenotype is 
NGF-dependent and can be rescued by NGF intranasal 
delivery (fig 6.10).  
Based on this result, I was able to develop an in vitro 
model that reproduced the phenotype observed in vivo.  This in 
vitro model allowed me to identify ambient extracellular levels 
of NGF as a key parameter that regulates, in a homeostatic 
way, the acquisition of the astrocyte phenotype that could be 
characterized as the A1 neurotoxic astrocyte phenotype.    
This astrocyte asthenic phenotype has been already 
described for several neurodegeneration models, such as 
3xTG-AD, and 5xFAD mouse models, as well as in human 
AD patients 34,38. 
It was therefore of interest to verify whether this 
asthenic neurotoxic phenotype of astrocytes, found in 
neurodegeneration models independent of NGF deficits, can 
also be reverted by NGF delivery in vivo. 
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Can this atrophy in 3xTG-AD mice be reverted by the 
administration of NGF? 
 
To address this point, I performed an intranasal NGF 
treatment on AD11 and 3xTG-AD mice from 1,5 to 2 months 
of age. The treatment lasted for 2 weeks and consisted of 3 
administrations per week of murine NGF, intranasally 
delivered.  
The morphology was evaluated once again by the 
analysis of 4 cell parameters such as Volume, Area, number of 
Branching Points and Length of the filaments on GFAP 
labelled hippocampus slices. For 3 of these 4 parameters I 
observed a statistically significant amelioration (i.e. increase in 
morphological complexity) after the treatment with NGF, 
compared to saline administration (see fig 6.10). The filaments 
became longer, determining an increase of area and a tendency 
increase of volume.  
 
These results demonstrate that the astrocytes 
atrophy can be reverted by NGF nasally administered. I 
found the same results with both AD11 and 3xTg-AD 
mice. 
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Particularly remarkable is that the 3xTg-AD is a model 
in which the onset of the Alzheimer neurodegeneration 
phenotype - and the astrocyte atrophy - is not due to an NGF 
imbalance as it is in AD11, but in both the intranasal NGF 
administration is sufficient to ameliorate the astrocytes 
morphology. 
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Fig 6.10 In vivo rescue of astrocytes atrophy, by NGF 
intranasally delivered, in different AD models  
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In paragraphs 6.6, 6.7 and 6.12, I presented data 
suggesting that primary cultured astrocytes are able to sense 
the extracellular levels of NGF and respond to NGF 
deprivation via calcium transients, becoming neurotoxic. Due 
to the intrinsic nature of in vitro work, which could be biased 
by differences in the activation state of primary astrocytes 
(Guttenplan & Liddelow, 2019), it was then of paramount 
importance and interest to study whether and how 
modulations of NGF levels affect astrocytes also in their 
natural environment: the brain parenchyma.  
For these reasons in our lab, based on my work, my 
colleague Dr. Alexia Tiberi carried out the in vivo experiments 
necessary to unveil the role of astrocytes in their natural 
environment. The experiments were discussed by Alexia, me 
and our supervisors, and were carried out in the Dr. Wen-Biao 
Gan lab at Skirball Institute and Department of Physiology 
and Neuroscience of the New York University.  
I will report here, in this and in the following 
paragraphs, selected findings from these experiments, for their 
tight connection with my work and their pivotal role in 
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depicting a complete scenario around the finding that we are 
unveiling.  
 As described in Material and Methods Chapter, to 
answer to the question: 
 
Can NGF levels modulate astrocyte calcium activity also in vivo? 
 
 We exploited adeno-associated viruses to induce the 
expression of a calcium reporter, Gcamp6, in astrocytes in the 
motor cortex of WT mice and measured the acute response of 
astrocytes to modulations of NGF levels. 
 
We first sought to investigate whether astrocytes could 
respond to changes in levels of NGF by applying the 
neurotrophin exogenously or by decreasing its levels via the 
neutralizing antibody αD11. In anesthetized mice, which were 
infected with AAV5-GfapABC1D-cyto-GCaMP6f-SV40 virus 
(GFAP.GCaMP6.cyto) to drive GCaMP6 expression in 
astrocytes, we imaged astrocyte calcium levels both as baseline 
activity and in response to an α1-receptor agonist 
phenylephrine (PE), which is capable of instantly inducing a 
strong calcium wave in astrocytes (Ding et al., 2013). PE is 
used to activate astrocytes that otherwise, in the anesthetized 
mouse, are more or less silent, in order to detect the global 
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activation capacity of these glial cells. Treatments were diluted 
in ACSF (NGF 1μg/ml, αD11 8µg/ml, PE 100 µM) and 
applied directly onto the cortical surface through a small 
cranial window over the motor cortex. Imaging began right 
after the application of the drugs.  
 
Astrocytic Ca2+ responses were first measured in the fine 
processes of the astrocytes during baseline activity (fig. 6.11 a). 
The effect of treatments on Ca2+ activity of astrocytes was 
monitored right after their application (t0), then after 5 (t5) 
and 10 minutes (t10). At any time-point, NGF did not induce 
any change in the Ca2+ baseline activity of astrocytes – data 
was thus pooled into a single bar (fig. 6.11 b).  
Interestingly though, decreasing the levels of NGF via 
αD11 treatment significantly increased astrocytic Ca2+ 
responses in fine processes (fig. 6.11 b). We then measured the 
bulk activation response of astrocytes, pretreated with NGF or 
αD11 10 for 10 minutes, to the adrenergic agonist PE (fig. 6.11 
c).  
We found that PE treatment induced a much larger 
astrocytic Ca2+ response in αD11 treated mice as compared 
with non-treated controls (fig. 6.11 d, e), while no difference 
was detected in the NGF treated cohort. 
                                                                                                  RESULTS - NMC - SNS 
 
 


























Fig 6.11 Lack of NGF increases astrocyte calcium 
(a) Representative two-photon images and traces of Ca2+ response 
in astrocytic processes expressing GCaMP6s before (NT) and after NGF 
(1μg/ml) or αD11 (8µg/ml) application in the motor cortex of an 
anesthetized mouse.  
 
(b) Quantification of the peak amplitude of Ca2+ transients in 
astrocytic processes during baseline (NT), right after (αD11 t0), after 5 
min (αD11 t5) and 10 min (αD11 t10) of αD11 (8μg/ml) application 
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(One-way ANOVA, NT vs.  αD11 NF t5 p < 0.0001; NT vs. 
αD11 t10 p<0.0001, n=4 per group, ~20 processes per animal).  
 
(c) Representative images of non-treated (NT), αD11 and NGF 
treated astrocytic response to phenylephrine (PE) 100 μM.  
 
(d) Representative traces of the bulk astrocytic response to PE 
administered at t0.  
 
(e) Quantification of the astrocytic response to PE 100 μM  
 
(One-way ANOVA, NT vs αD11, p=0.0001; NT vs NGF, 
n.s.; NT αD11 vs NGF, p=0.0001; n=3, 10 cells per animal). 
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6.15 Reducing NGF levels increases astrocyte 
calcium in the awake behaving animal 
 
Since the lack of NGF in cortical tissue relayed such a 
powerful response from astrocytes we decided to focus on this 
treatment, switching to the more complex system of the awake 
behaving animal.  
 
Can NGF levels modulate astrocyte calcium activity also in vivo, 
in awake behaving animals? 
 
We performed 2-photon imaging in mice previously 
injected with AAV5-GfapABC1D-cyto-GCaMP6f-SV40 virus 
(GFAP.GCaMP6.cyto) to drive Gcamp6f expression in 
astrocytes. We then imaged the astrocytic calcium response in 
the mouse motor cortex during a running task (120 seconds 
total, running 20-100).  
It has already been reported that astrocytes can respond 
to running with a wide and global calcium response that 
interests both soma and fine processes.  
We thus quantified the response to such task under the 
influence of αD11 or NT conditions.  
In a similar manner to anesthetized conditions, in the 
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awake behaving animal, lack of NGF increases astrocytic 
activity both in the soma (fig. 6.12 b, c) and processes (fig. 6.12 
d, e).  
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Figure 6.12 Lack of NGF increases astrocytic activity in the 
awake behaving animal 
(a) Representative images of the astrocytic responses.  
(b) Soma peak amplitude (2tailed t-test, p=0.0012) and  
(c) traces (2way ANOVA, p<0.0001) to running in NT and 
αD11 treated conditions.  
(d) Process peak amplitude (2tailed t-test, p<0.0001) and  
(e) traces (2way ANOVA, p<0.0001) to running in NT and 
αD11 treated conditions (n=4 per group, ~10 cells per animal). 





Next, we used another NGF inhibitor, the commercial 
TrkAFc, to further confirm the effect of the lack of NGF onto 
astrocyte calcium levels. As for αD11, TrkAFc was able to 
consistently increase astrocyte calcium in their processes (fig. 
6.13 d, e). 
 
In conclusion, we have tackled the in vivo extension of 
the in vitro data by using in vivo 2-photon microscopy. 
We monitored the effects of NGF on astrocyte 
physiology, by monitoring the changes in calcium activity of 
these cells during modulations of NGF levels in the 
extracellular environment.  
 
We discovered that, also in vivo, while NGF exerted 
no effect, a lack of the neurotrophin, induced by acute 
anti NGF injection, increased astrocyte calcium activity 
in the anesthetized mouse as well as in the awake 
behaving animal. 
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Figure 6.13 Inhibition of NGF via TrkAFc increases astrocytic 
calcium activity 
(a) Representative images of the astrocytic response to TrkAFc. 
(b) Soma peak amplitudes (2tailed t test, n.s.) and 
(c) traces (2way ANOVA, p= 0.0016) of the astrocytic 
Ca2+. 
(d) Process peak amplitudes (2tailed t test, p=0.001) and 
(e) traces (2way ANOVA, p= 0.0103)  
 
(n=3 per group, ~10 cells per animal). 
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6.16 Upregulation of NGF translation after 5 min of 
NGF deprivation 
 
What adaptive or homeostatic function could potentially 
be fulfilled by A1 astrocytes, in their natural context, remains 
an open question. We should consider the A1 neurotoxic 
phenotype as a state reached by the astrocytes after a 
prolonged chronic insult and after the homeostatic responses 
of astrocytes, to react to different stress insults, have been 
exhausted. But what are the early events after an acute NGF 
starvation? 
If these are the premises, the short-term calcium 
response of astrocytes to anti NGF could be considered as the 
triggering of a rapid homeostatic alert signal. If the NGF 
deprivation is read by astrocytes as an insult signal, to which a 
homeostatic response should be provided, we argued that 
astrocytes might react also attempting to restore the NGF 
levels. 
What are the early events after an acute NGF starvation? Does 
the astrocyte react to acute NGF deprivation also translating new NGF 
protein? 
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To answer this question, (in cultured astrocytes, as above 
and M&M) I measured the astrocyte intracellular NGF protein 
after 5 minutes of acute exposure to αD11 (800 ng/ml) or anti 
V5 (800 ng/ml) antibodies, plus or minus the protein synthesis 
inhibitor geneticin (G418, 300 µg/ml). Cell extracts were 
immunoprecipitated and analyzed by and immunoblotting 
technique (for details, see M&M paragraph 8.17).  
Geneticin (G418), an aminoglycoside antibiotic, is an 
elongation inhibitor of 80 S ribosomes that blocks polypeptide 
synthesis by inhibiting the elongation step in both prokaryotic 
and eukaryotic cells. 
 
An NGF pulse clearly appears after only 5 minutes 
from acute NGF starvation by αD11 antibody.  
 
The NGF pulse was absent in naïve untreated and in 
anti- V5 treated astrocytes (fig 6.14). The geneticin was also 
able to abolish the NGF pulse elicited by αD11 administration, 
demonstrating that the NGF pulse is newly synthetized NGF 
i.e. not an amount previously stored in intracellular 
compartment (fig 6.14). 
This pulse of NGF synthesis results from the 
translational activation of the NGF mRNA, as a homeostatic 
response of the astrocyte to the lower ambient levels of NGF. 
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As a consequence of this finding, we can draw a picture 
whereby astrocytes would have a pool of NGF mRNA readily 
available, but in a state of translational repression. The 
mechanism of this translational repression remains to be 
investigated, but could involve specific microRNAs, 
polyadenylation control or specific translation initiation 
factors.  
Elucidating this mechanism of translational control will 
be the object of future research.  One can postulate that the 
Calcium signal rapidly activated upon anti-NGF addition 
might provide a signal to induce the synthesis of NGF. 
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Figure 6.14 Upregulation of intracellular NGF translation after 
5 min of extracellular NGF starvation  
The astrocytes react to NGF starvation translating NGF: WB 
after Immunoprecipitation.  
Intracellular NGF protein after 5 minutes of acute exposure to 
αD11 (800 ng/ml), or-V5 (800 ng/ml) antibodies, geneticin (G418, 
300 µg/ml) and geneticin (G418, 300 µg/ml) + αD11 (800 ng/ml).  
The last lane shows NGF standard immunoreactivity as internal 
control.  
 




























Phospho TrkA marked intracellular vesicles, blebbing from Endoplasmic Reticulum in an 
NGF-starved astrocyte.  
Green is pTrkA, red is GFAP. Confocal microscopy.  
Credit: Nicola Maria Carucci, 2015 
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he neurotrophin Nerve Growth Factor 
(NGF) promotes a variety of responses, 
including increased transmitter production, 
Trk receptor production, neurite outgrowth, and enhanced 
neuronal survival (Barker and Murphy, 1992; Yuen et al., 1996; 
Frade and Barde, 1998; Gustilo et al., 1999). In the brain it is 
believed to act mainly on cholinergic neurons of the basal 
forebrain (Hefti, 1986). 
 
Astrocytes have been implicated in the trophic support 
of developing neurons, and influencing the structure of mature 
T 
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neurons (Jordan, 1999). In addition, astrocytes have been 
proposed to function in inducing and stabilizing the formation 
of new synapses (Ullian et al., 2001), being required for 
synapse formation and maintenance. 
 
7.1 Astrocytes and NGF: secretion, signalling and 
mouse models  
 
Whether NGF can be produced in physiological 
conditions by astrocytes and if astrocytes express NGF high 
affinity (NTRK1) and low affinity (p75NTR) receptors in vivo 
and in vitro are non-matter of debate anymore. Indeed, NGF 
synthesis by astrocytes was initially believed to occur only in 
pathological conditions to support regeneration of neuronal 
processes and influence synaptic rearrangements (Althaus and 
Richter-Landsberg, 2000). 
In my thesis I demonstrate that NGF can be produced 
by astrocytes in vitro and that both TrkA and p75NTR NGF 
receptors are expressed on cultured astrocytes. 
To study whether NGF can influence astrocyte 
physiology I first relied on the AD11 mouse model in which 
mature NGF biological activity is blocked by the expression of 
a recombinant neutralizing antibody, leading to an imbalance 
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between NGF/proNGF signalling (Ruberti 2000, Capsoni 
2000, Capsoni 2010 PNAS, Capsoni & Cattaneo 2006).  
In this mouse model I showed that astrocytes stained 
with an antibody against GFAP have a reduced morphological 
complexity (max diff at 2 m.o.a.), due to reduced volume and 
ramifications.  
Fig 7.1 AD-like progression in AD11 mice  
The major hallmarks are pointed out at specific times. Note the 
astrocytic atrophy at 2 months of age, when other AD hallmarks are not 
still present. 
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The collected evidence leads to the conclusion that the 
morphological changes observed in astrocytes are really due to 
a structural change of these cells and could not be explained by 
a fluctuation of cell marker expression. The astrocytes in 
AD11 mice are clearly atrophic: they show a marked shrinkage 
at 2 months of age i.e. in an early pre-symptomatic phase when 
other AD hallmarks are not still present in these animals (fig 
7.1).  
 
7.2 Pathological implications of atrophic astrocytes 
  
Morphological atrophy of astrocytes at the early stages 
of the AD may have several pathologically relevant 
consequences. First and foremost, this may result in decrease 
of astroglial synaptic coverage. Perisynaptic glial membranes 
that enwrap most (~70% in hippocampus) of the synapses in 
the CNS form “astroglial cradle” fundamental for maintenance 
of synaptic transmission through multiple molecular cascades 
sustaining homeostasis of the synaptic cleft and supplying 
neuronal terminals with neurotransmitter precursors 
(Nedergaard and Verkhratsky 2012; Verkhratsky and 
Nedergaard 2014). Reduced synaptic coverage may therefore 
compromise synaptic strength and even promote synaptic loss. 
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This synaptic loss is generally considered to represent the 
earliest morphological symptoms of AD responsible for early 
signs of cognitive deficit (Coleman and others 2004; Terry 
2000). The degree of synaptic loss has been claimed to 
correlate with the severity of dementia (DeKosky and Scheff 
1990; Samuel and others 1994). In addition, asthenic astrocytes 
cannot support synaptogenesis (Eroglu and Barres 2010) thus 
affecting regeneration. 
 
Comparable astrocyte asthenia has been already 
described in Alzheimer’s mouse models such as, for example, 
3xTG-AD34,38 mice as well as in human AD patients, but the 
signals that determine this phenotype have not been 
understood. Astroglial reactivity (defined by an increase in 
GFAP or S100β expression) was frequently described in the 
AD post-mortem tissues (Beach and McGeer 1988; Griffin 
and others 1989; Meda and others 2001; Mrak and Griffin 
2005), and even some correlation between increased GFAP 
levels and the Braak stage of AD were claimed (Simpson and 
others 2010). I found the same results with both AD11 and 
3xTg-AD mice.  
Particularly remarkable is that the 3xTg-AD is a model 
in which the onset of neurodegeneration - and the astrocyte 
atrophy - is not due to an NGF imbalance as in AD11. Yet, in 
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both AD11 and 3xTg-AD mice, the intranasal NGF 




7.3 Early events after NGF deprivation 
 
To understand the consequences of this astrocytic 
atrophy I replicated this phenotype in vitro. This step has been 
fundamental to show that atrophic astrocytes are indeed 
reactive cells. The first evidence came from the fact that NGF 
deprivation in cultured astrocytes causes fast and durable 
calcium oscillations within 5 minutes. This data fits with the 
fact that reactive astrocytes generate aberrant Ca2+ signals 
represented by spontaneous Ca2+ oscillations and abnormal 
Ca2+ waves (Kuchibhotla and others 2009). On the contrary, I 
found that astrocytes, cultured in the same conditions, are deaf 
to NGF.  
Molecular mechanisms triggering astroglial reactivity and 
Calcium responses remain debated and should be more 
intensely addressed. There are indications that soluble β-
amyloid induces abnormal Ca2+ oscillations in cultured primary 
astrocytes (Abramov and others 2003; Abramov and others 
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2004), although these results were not universally confirmed 
(Grolla and others 2013; Ronco and others 2014). Chronic 
exposure of cultured astrocytes to β-amyloid resulted in 
significant changes in the Ca2+ signalling toolkit in the 
hippocampus but not in the entorhinal cortex (Grolla and 
others 2013). 
In addition to that, I found that the changes in astrocyte 
morphology are accompanied by transcriptomic changes 
which identify the astrocytes resulting from anti NGF 
treatment as harbouring a transcriptional fingerprint typical of 
reactive type A1 neurotoxic astrocytes70. The RNA modulation 
occurring 24 hours after the exposure to the αD11 anti-NGF 
antibody was consistent with a pan reactive phenotype and, in 
particular, with a full A1-like activation. On the other side, 
there was a downregulation of the mRNAs linked to a A2-
specific neuroprotective phenotype. Altogether, I conclude 
that a long exposure of astrocytes to reduced levels of NGF 
activates a neurotoxic A1 phenotype. This neurotoxic 
phenotype of astrocytes has been described as the executor of 
the neurodegeneration process in the course of Alzheimer’s 
disease and other neurodegenerative diseases.  
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7.4 Long term events after NGF deprivation 
 
The identification of the “killer” molecule(s) secreted 
from neurotoxic A1 astrocytes is currently a top priority in the 
field. I have developed in this thesis an in vitro model to 
reproducibly induce the neurotoxic A1 phenotype by a simple 
“negative” signal (anti NGF antibodies) and this forms a solid 
basis to set up a screening functional assay for the 
identification of the killer molecule(s) produced by A1 
neurotoxic astrocytes.  
At the beginning, transcriptomic analysis of microglia in 
neurodegenerative models has provided some valuable starting 
points for how these cells respond locally at neurodegenerative 
foci, giving rise to the idea of disease-associated microglia 
(DAM) or of the microglial neurodegenerative (MGnD) 
phenotype. Interestingly, these microglia differentially express 
markers that are nowadays traditionally associated with both 
M1 and M2 microglia - i.e., markers from both populations are 
either upregulated or downregulated (Shi & Holtzman, 2018). 
At a broad level, this signature is associated with increased 
expression of phagocytic and inflammatory genes, as well as 
regulators of microglial ontogeny, specifically colony 
stimulating factor 1 (Csf1). 
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Coming back to astrocytes, transcriptional analysis has 
demonstrated subtype heterogeneity among reactive astrocytes 
that depends heavily on the extracellular environment and type 
of injury. For example, reactive astrocytes produced in the 
context of either neuroinflammation induced by systemic LPS 
injection or middle cerebral artery occlusion (MCAO) 
upregulate transcription of a core set of “pan-reactive” genes. 
However, sub-populations of reactive astrocytes differentially 
regulate transcriptional modules, enabling them to be further 
categorized and robustly discriminated. Subsequent research 
has designated the reactive sub-populations induced by 
neuroinflammation (LPS) and ischemia (MACO) as the “A1” 
and “A2” reactive astrocyte subtypes69. Very interestingly, 
astrocyte-conditioned medium from A1 astrocytes (A1-ACM) 
is potentially neurotoxic69. 
 
7.5 Adaptive homeostatic functions of astrocytes 
 
What adaptive or homeostatic function could potentially 
be fulfilled by A1 astrocytes remains an open question. The 
removal of unsalvageable neurons from neural circuits is one 
potential evolutionary reason for their existence, i.e. 
eliminating those which have lost functional synaptic 
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connections or have become virally compromised. Eliminating 
unsupported neurons could also have significance during 
development.  
One can also consider the A1 neuroxic phenotype as a 
state reached by the astrocytes after a prolonged chronic insult 
has worn them out and their homeostatic responses to combat 
the stress insult have been unsuccessful. In this respect, the 
short-term calcium response of astrocytes to anti NGF could 
be considered as the triggering of a rapid homeostatic alert 
signal. This homeostatic response results in the translational 
activation of the NGF mRNA, as a response of the astrocyte 
to the lower ambient levels of NGF (fig 6.14).   
If the NGF deprivation becomes chronic, I propose that 
the homeostatic response of astrocyte fails, and the astrocytes 
start acquiring a neurotoxic phenotype. Microglia are actively 
involved with synaptic pruning during neurodevelopment and 
A1 astrocytes could plausibly serve a complementary or 
parallel function (Hinkle et al., 2019). Regardless of their 
ontological basis, A1 phenotype regulators should likely be 
seen as candidate targets for therapeutic interventions. 
Recent evidence established a clear link between 
immune cell‐induced reactive astrocyte function that leads to 
neuronal and oligodendroglial cell death. Most strikingly, 
reactive astrocytes are localized to regions of degeneration in 
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human AD patient post-mortem tissue69, mouse models of 
tauopathy (Shi et al., 2017), and many other neurodegenerative 
diseases69 (Rothhammer et al., 2018; Yun et al., 2018; Sadick 
and Liddelow, 2018). 
Couple of dozens of mice AD-like strains have been 
produced in a recent decade; all of them bear mutant genes 
associated with family AD in different combinations (Gotz 
and others 2012; Oddo and others 2003). Most of these mice 
express mutant genes for amyloid precursor proteins and or 
presenilins, which allows production of β-amyloid in animals, 
wild types of which are lacking this pathway. Reduction of 
astroglial profiles together with decrease in astroglial 
complexity and number of principal and secondary processes 
have been quantified in hippocampi from mice with 
experimental amyloidosis (the PDAPP-J20 mice expressing 
mutant APP; Beauquis and others 2013; Beauquis and others 
2014) and in 3xTg-AD mice that display senile plaques and 
tangles (Olabarria and others 2010; Verkhratsky and others 
2010). Importantly, these atrophic changes occurred before the 
emergence of amyloid plaques, i.e., before 12 months of age 
for 3xTG-AD mice). Signs of astroglial atrophy have been 
found in different regions of the brain (Verkhratsky and others 
2014). In AD animal models, astro-degenerative changes are 
complemented by astroglial reactivity. Reactive, hypertrophic 
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astrocytes occur in hippocampus in response to development 
of senile plaques and perivascular β-amyloid deposits, with 
which reactive astrocytes are associated (Olabarria and others 
2010).  
Several studies have demonstrated that the 
survival/death choice of NGF-dependent neurons is a 
complex mechanism since it depends upon an intricate balance 
between proNGF/mature NGF and on the spatio-temporal 
expression of their receptors TrkA, p75NTR and Sortilin66. 
However, all these data point to mechanisms that do not take 
into account the fact that in the brain a large population of 
cells are of glial nature and do not take into account the 
interaction between neurons and glial cells, particularly 
astrocytes.  
 
7.6 A new mechanism of neuronal death mediated 
by NGF-deprived neurotoxic astrocytes 
 
Here I propose a further complexity and regulatory step 
provided by the astrocytes that could explain this and other 
phenomena already observed.  
For example, it has been reported that primary 
hippocampal neurons, that do not express NGF receptors, 
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after 48 h of NGF exposure die following NGF withdrawal.  
This result has not been explained and are still poorly 
understood but could be explained considering the mechanism 
that I propose, i.e. that NGF deprivation induces the A1 
phenotype in astrocytes and in turn they trigger neuronal 
degeneration.  
I set up neuron and astrocytes cultures and co-cultures 
and I demonstrated that the NGF neutralization leads to a 
neuronal impairment only if the neurons are co-plated with 
astrocytes.  
This experimental approach gave me the opportunity to 
gain insights into the mechanism of neuronal death mediated 
by NGF-deprived neurotoxic astrocytes. I postulated that the 
cell death might involve the production of the toxic species of 
Aβ peptide, the so called Aβ oligomers. To test this 
hypothesis, I exploited a recombinant small antibody fragment 
scFvA13 (Meli et al 2009 JMB, 2014 Nat Comm), that binds 
selectively Aβ oligomers with no binding affinity for Aβ 
monomers nor for Aβ fibrils (Meli et al 2009 and 2014). 
Interestingly, the neuronal impairment is reduced when NGF 
is neutralized concomitantly with the amyloid β oligomers 
neutralization with A13 antibody, or concomitantly with the 
glutamate ionotropic receptors blockade exerted by kynurenic 
acid. 
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This indicates that the neurotoxic effects of deprivation 
of NGF, mediated by the astrocytes, might imply the 
production of β amyloid oligomers or excitotoxicity. 
Is this relevant for AD neurodegeneration? Increasing 
evidence indicates that astrocyte glutamatergic homeostasis is 
disrupted in AD and, more in general, in neurodegenerative 
diseases. Reduced glutamate transporters in association with 
increased levels of glutamate in the CSF are potential 
biomarkers to identify early changes. Excitotoxicity has been 
implicated in several other brain disorders, but early astrocyte 
glutamatergic dysfunction in brain regions commonly 
associated with AD provides an interesting avenue with plenty 
of potential biomarker targets (Carter et al., 2019). 
We have tackled the in vivo extension of the in vitro data 
by using in vivo 2-photon microscopy. We monitored the 
effects of NGF on astrocyte physiology, by monitoring the 
changes in calcium activity of these cells during modulations of 
NGF levels in the extracellular environment. We discovered 
that, also in vivo, while NGF exerted no effect, a lack of the 
neurotrophin, induced by acute anti NGF injection, increased 
astrocyte calcium activity in the anesthetized mouse as well as 
in the awake behaving animal. 
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7.7. Widening the potential clinical application of 
NGF  
 
Taken all together, the data shown in this thesis strongly 
suggest NGF as potential treatment for neurodegeneration. 
NGF has been considered to have therapeutic potential for 
Alzheimer’s disease due to its neuroprotective action on 
cholinergic neurons.  
Here I show that the extracellular levels of NGF 
influence the reactive states of astrocytes and thus restoring its 
levels might reduce the pro-neurodegenerative state of these 
cells. Importantly, the latter statement applies not only to 
Alzheimer’s disease but also to human several diseases in 
which astrocytes contribute to neurodegeneration, thus 
widening the potential clinical application of this neurotrophin. 






















Human astrocyte contacting blood vessels. 
Credit: Liam O'Leary, The Douglas Research Centre. 
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6129 mice were purchased from The Jackson 
Laboratory (Bar Harbor, ME). 
AD11 mice, VH mice control (Ruberti, 
Capsoni et al. 2000) and proNGF mice (Tiveron et al., 2013) 
from an in-house colony were used. For experiments involving 
AD11 mice, littermates were used as controls for the IHC, 
since AD11 has a C57BL/6 x SJL background.  
B 
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The 3xTG mice are homozygous triple-transgenic AD 
mice possessing PS1M146V, AβPPswe, and tauP301L transgenes 
purchased from The Jackson Laboratory (Bar Harbor, ME). 
Genotyping was performed by PCR analysis of tail DNA 
according to the best genotyping procedure specific for each 
strain. 
All experiments with mice were performed according to 
the national and international laws for laboratory animal 
welfare and experimentation (EU directive n. 2010/63/EU 
and Italian DL n. 26 04/03/2014). 
Mice were kept under a 12-h dark to light cycle, with 
food and water ad libitum.  
 
8.2 Intranasal Delivery 
 
Intranasal administration was performed on 
anaesthetized mice as follows. First, 2,2,2-tribromethanol 
(Sigma–Aldrich) was dissolved in absolute ethanol at the 
concentration of 1 g/ml and stored at -20°C in the dark. After 
dilution in 0.9% NaCl at the final concentration of 2.5%, it 
was injected i.p. at the dosage of 10 μl/g of body weight to 
induce anesthesia, which followed within 5–10 min after 
injection.  
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After anesthesia, mice were laid on their back, with the 
head in upright position. The experiment required 10 μM 
solution of mouse NGF in PBS administered intranasally to 
mice, 3 μl at a time, alternating the nostrils, with a lapse of 2 
min between each administration, for a total of 14 times in a 
single session. 
 The treatment lasted for 2 weeks and consisted of 3 
sessions per week. During these procedures, the nostrils were 
always kept open. As control, mice were treated with PBS. 
 
 
8.3 Cell cultures 
 
All primary cell cultures were grown and maintained in 
DMEM/F12 or RPMI (Thermo Fisher Scientific, MA, USA 
#11835-063) medium containing 1% penicillin/streptomycin 
(Euroclone, MI, Italy #ECB3001D), 1% Glutamax (Thermo 
Fisher Scientific, MA, USA; #35050-038) and 10% fetal 
bovine serum (FBS) (Euroclone, MI, Italy #ECS0180l) in 5% 
CO2 at 37°C incubator.  
Primary astrocyte cells were derived from the brains of 
B6129 at postnatal day 3-4 as described by Butovsky et al., 
2014. Astrocytes were maintained in Dulbecco's modified 
Eagle's medium (DMEM/F12) (Thermo Fisher Scientific, MA, 
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USA #21331-020) containing 1% penicillin/streptomycin, 1% 
Glutamax and 10% FBS in 5% CO2 pH 7.4 at 37 °C. 
Microglia were eliminated from the mixed primary glial 
cultures by mild shaking. Astrocytes, after 14 days in culture, 
were detached by mild trypsinization (10 min, 0.01% of trypsin 
(Thermo Fisher Scientific, MA, USA), then collected and re-
suspended in DMEM/F12 with 1% penicillin/streptomycin, 
1% Glutamax and 10% FBS and plated on the appropriate 
support 24hrs before the experiments to allow cells to attach 
to the substrate. 
Primary cortical and hippocampal neurons were 
prepared at postnatal day 0 as described by Beaudoin et al., 
2012. Briefly, animals were decapitated, the brain was rapidly 
excised and placed into ice-cold Hanks Buffered Saline 
Solution (HBSS) (Thermo Fisher Scientific, MA, USA; 
#14180046). Hippocampi and/or cortex were removed and 
digested for 15 min at 37°C in DMEM-F12 containing 0.1% 
of trypsin (Thermo Fisher Scientific, MA, USA). Thereafter, 
tissue was transferred in culture medium containing 10% FBS 
and gently disrupted using a polished Pasteur pipette. 
Following centrifugation at 4°C for 8 min at 800 r.p.m. cells 
were resuspended in fresh DMEM containing 1% Glutamax, 
10% FBS, 2% B27 supplement (Gibco, MA, USA, 
#17504044), 6 mg/ml Glucose, 12,5 uM Glutamate, 10 ug/ml 
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Gentamicin (Gibco, MA, USA, #15710-049) and plated at a 
density of approx. 150,000 cells per coverslip after proper 
poly-D-lysine coating (Sigma Aldrich, MO, USA, #P1024).  
Cells were kept at 37°C in 5% CO2. After 12-24 hours, 
medium was replaced with pre-warmed Neurobasal A medium 
(Thermo Fisher Scienti_c, MA, USA #10888-022) containing 
2% of B27 supplement, 2.5 uM Glutamax, and 10 ug/ml 
Gentamicin. The experiments were performed at DIV 17-19. 
 
8.4 Immunoblot analysis 
 
Primary astrocytes were plated in 6 well plates at a 
density of 5x105/well in culture medium. Cells were treated 
with the different drugs as mentioned in each corresponding 
paragraph and sequentially collected and lysed in ice-cold 
RIPA buffer (50 mm Tris-HCl, pH 7.6, 150 mm NaCl, 1% 
Igepal, 1 mm EDTA, 1% SDS, 0,5% sodium deoxycholate, 1x 
protease and phosphatase inhibitor cocktails (Roche, Basel; 
CH)). After sonication, cells were collected by centrifugation 
for 15 min at 4°C (13,000 r.p.m.).  
Protein concentrations of the cell lysates were measured 
using the Bradford method. Lysates (20 to 50 ug) were then 
separated on a 10% SDS-PAGE, transferred to a nitrocellulose 
membrane, and analyzed by Western blotting.  
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After transfer in nitrocellulose, the membrane was 
blocked for 1h and incubated with the appropriate primary 
antibodies. Inhibitors of NGF-receptors used: 200 nM K252a 
(Abcam, Cambridge, UK; #ab120419), TAT-pep5 p75NTR 
(Millipore, CA, USA; #506181) (Yamashita Tohyama, 2003), 
were added 30 min before treatment.  
The following primary antibodies were used: anti-TrkA 
1:1000 (Millipore, CA, USA; #06-574), anti-pTrkA 1:1000 
(Y794) (Rajagopal, Chen, Lee, Chao, 2004) kindly provided by 
M. V. Cao (New York University School of Medicine, New 
York, USA) anti Akt 1:1000 (Cell Signaling Technology, MA, 
USA; #C67E7) , anti p-Akt 1:1000 (Cell Signaling Technology 
#130386), ant-Erk 1:1000 (Promega, WI, USA; #V114A), 
anti-pErk 1:1000 (Cell Signaling Technology, MA, USA; 
#4370S), anti-c-Jun 1:1000 (Cell Signaling Technology, MA, 
USA; #60A8), anti-phospho-c-Jun 1:1000 (Cell Signaling 
Technology, MA, USA; #9261), anti-p75 1:1000 (Millipore, 
CA, USA; AB1554), anti-GAPDH 1:20000 (Fitzgerald, MA, 
USA; #10R-G109a), anti-tubulin 1:20000 (Sigma Aldrich, MO, 
USA; #T5168). After incubation with the appropriate HRP-
conjugated secondary antibody (Santa Cruz, TX, USA; anti-
mouse #sc-2005, anti-rabbit #sc-2004), membranes were 
developed using ECL-enhanced chemiluminescence kit (Bio-
Rad, CA, USA).  
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Densitometric analyses were performed using the NIH 




Primary astrocytes were plated on coverslips in 24-well 
plates coated with poly-D-lysine (1x105 cells/well) in culture 
medium. After 18 hrs, cells were fixed with 2% PFA, and 
blocked for 1 hr at room temperature. Coverslips were 
incubated overnight at 4°C in primary antibody: rabbit anti-
Glial Fibrillary Acidic Protein (Dako, Cytomation, Glostrup, 
Denmark, Z0334, 1: 500) or goat Anti-Glial Fibrillary Acidic 
Protein (Santa Cruz Biotechnology, California, USA, sc-6170, 
1:300) 1:500 anti-TrkA 1:100 (MNAC13 (Covaceuszach, 
Cattaneo, Lamba, 2005)), anti-p75 1:500 (Millipore, CA, USA; 
AB1554). 
After three washings, cells were incubated for 1 hr with 
appropriate secondary antibodies (1:500) anti-rabbit Alexa-
Fluor 555, anti-mouse Alexa-Fluor 488, Thermo Fisher 
Scientific, MA, USA; A-21428; A-21201). Coverslips were 
mounted on glass slides in Fluoromount (Sigma Aldrich, MO, 
USA #F6057) and confocal images were acquired using a 
Leica SP2 confocal microscope (Leica Microsystems, Wetzlar, 
Germany). 
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8.6 Immunofluorescence on slice 
 
Mice were sacrificed with a lethal dose of carbon dioxide 
and immediately underwent a perfusion procedure. Blood was 
firstly transcardially washed out with cold phosphate buffer 
saline solution (PBS), then tissues were fixed with cold 4% 
paraformaldehyde in 0.1 M pH 7.4 phosphate buffer (PBS) 
with a peristaltic pump for 10 minutes. 
Brains were dissected, post-fixed for 48 hrs at 4°C, 
washed from paraformaldehyde with PBS and cryoprotected in 
30% sucrose/PBS at 4°C overnight. Dry ice frozen brains 
were cut into 40 um coronal sections with a cryostat 
microtome (Leica Microsystems, Wetzlar, Germany) at -20°C. 
Sections were rinsed for three times in PBS and incubated with 
a mix of primary antibodies in PBS 0.3% Triton X-100 
(Applichem, BioChemica, Darmstadt, Germany) overnight at 
room temperature.  
Astrocytes were stained with rabbit anti-Glial Fibrillary 
Acidic Protein (Dako, Cytomation, Glostrup, Denmark, 
Z0334, 1: 500) or goat Anti-Glial Fibrillary Acidic Protein 
(Santa Cruz Biotechnology, California, USA, sc-6170, 1:300). 
NGF receptors were identified by anti-TrkA (clone MNAC13, 
1:300, (Cattaneo et al., 1999)) and anti-p75 (Promega 
Corporation, Madison, WI, USA, G3231, 1:300). After three 
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10 min rinses in PBS at RT, sections were incubated for 2 hrs 
at RT in a mix of the appropriate secondary antibodies - anti-
mouse/rabbit/goat/rat Alexa-Fluor 488/555/649 conjugated 
(Thermo Fisher Scientific, MA, USA; A-21428 diluted 1:500) 
followed by three 10 min rinses in PBS. DAPI was applied for 
5 min in the second rinse, dissolved in the PBS solution.  
To exclude non-specific signals of secondary antibodies, 
sections from each group of animals have also been stained 
with secondary antibody alone, following the same 
experimental procedure but omitting the primary antibodies. 
 
8.7 Flow cytometry  
 
Primary astrocytes were plated in 6 well plates at a 
density of 5x102 cells/well. 
Cells were washed with PBS and collected for analysis. 
Data acquisition: A Sorter S3 (BioRad, CA, USA) with a single 
488 nm (100 mW) excitation laser was used. The gating 
strategy 
was decided on the FSC and SCC scatter plots, in order 
to gate out debris. Filters are based on the emission spectra of 
the fluorochromes RhodamineB or DyeRed.  
The analysis was performed using the FlowJo software 
(FlowJo, LLC, Ashland, Ore., USA).  
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8.8 Microarray transcriptome analysis 
 
Primary astrocytes were treated with drugs as described 
in the experimental paragraphs. RNA isolation, amplification, 
and labeling were performed using a RNeasy mini kit 
according to manufacturer's protocol (Qiagen). Total RNA 
was isolated from these cells using Trizol (Invitrogen) and 
DNAse treated by Qiagen columns. Quality and integrity of 
each sample was checked using the Agilent BioAnalyzer 2100 
(Agilent RNA 6000 nano kit): samples with an RNA Integrity 
Number (RIN) index lower than 8.0 were discarded. All the 
experimental steps involving the labeling, hybridization, and 
washing of the samples were done following the standard one-
color micro Agilent protocol.  
The gene expression profiling was performed using the 
Microarray Agilent Platform. 200ng of RNA was labeled with 
Low Input Quick Amp Labeling Kit One-Color (Agilent 
Technologies), purified and hybridized overnight onto the 
Agilent 8X60K whole mouse genome oligonucleotide 
microarrays (Grid ID 028005) according to the manufacturer's 
instructions for one-color protocol.  
The Agilent DNA microarray scanner (model G2505C) 
was used for slide acquisition and spot analysis was performed 
with Feature Extraction software ver 10.7 (Agilent 
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Technologies). Data filtering and analysis were performed 
using R-Bioconductor and Microsoft Excel. All the features 
with the flag gIsWellAboveBG=0 (too close to background) 
were filtered out and excluded from the following analysis. 
Filtered data were normalized by aligning samples to the 75th 
percentile. Differentially expressed genes were selected by a 
combination of fold change and moderated T-test thresholds 
(R Limma test p_0.05; |Log2 fold-change|>1.0). Principal 
Component Analysis, Multi-Dimensional Scaling, Hierarchical 
Clustering of samples and volcano plots were computed using 
the open source R Studio (Boston, MA, USA). 
 
8.9 Neuron/astrocytes co-cultures 
 
For neuron/astrocytes co-cultures, at DIV 17-19 for 
neurons, primary astrocytes were seeded onto cultured 
hippocampal neurons (1x105 cells/well). 
The culture was maintained in Neurobasal-A 
supplemented with 2% B27, 2mM L-Glutamine and 10 ug/ml 
gentamicin and used after 24 hrs for experiments. Co-cultures, 
treated as described in the experimental part, were fixed in 2% 
PFA and 5% sucrose for 10 min, washed in PBS and blocked 
for 1 hr at room temperature in BSA 1%. Incubation with 
primary antibody was performed at the following 
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concentrations: anti-PSD95 1:500 (Abcam Cambridge, UK; 
ab9909), anti-actin 1:500 (Sigma Aldrich, MO, USA A-3853;), 
rabbit anti-Glial Fibrillary Acidic Protein (Dako, Cytomation, 
Glostrup, Denmark, Z0334, 1: 500) or goat Anti-Glial 
Fibrillary Acidic Protein (Santa Cruz Biotechnology, 
California, USA, sc-6170, 1:300). For image acquisition, 
coverslips were mounted on glass slides in Fluoromount 
(Sigma Aldrich, MO, USA, F4680-25ML). 
 
8.10 Confocal microscopy and image analysis 
 
Image Analysis Images from AD11, VH and WT mice 
were acquired with a confocal laser scanning microscope (TCS 
SP2; Leica Microsystem, Wetzlar, Germany) on slices labelled 
as previously described for GFAP detection. 10 stacks per 
region per mice were obtained. On the Z axis, images were 
taken every 0.4 um. Region of interest for morphological 
changes were the hippocampus. Image elaboration and analysis 
was conducted using Bitplane software Imaris (Zurich, 
Switzerland). Images were acquired with a confocal 
microscope (Leica TCS SP2) using an oil objective: HCX PL 
APO 63.0X OIL (NA=1.40), and pinhole was set to 1 AU. 
Sequential illumination with Ar 561 and Ar 488 laser lines was 
used to detect the immunofluorescence.  
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Points of colocalization were localized when a merging 
area in the same cell was evident, showing a yellow resulting 
color from the overlap of two green-red signals, and they were 
verified by analysis on the z-axes with 1 um-stacks using the 
Pearson index tool provided from ImageJ 1.44p software 
(ImageJ.nih.gov). 
 
8.11 Data Analysis and statistics 
 
Data are presented as means +/- s.d. unless otherwise 
noted, using Origin (OriginLab Corporation, MA, USA) and 
Prism (GraphPad Software, San Diego, CA, USA). Means 
were compared using the unpaired or paired t-test.  
Multiple comparisons were made using one-way 
ANOVA test, followed by a post-hoc Bonferroni test.  
The variance of each dataset was measured with an F 
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8.12 Transgenic mice for in vivo Ca2+ experiments 
 
Wild-type mice (C57J\BL) were used for viral injection 
at 1-1.5 month of age to achieve expression of GCamp6f in 
astrocytes. Mice were group-housed (5 per cage) in the Science 
Building Animal Facility at New York University Medical 
Center.  
Mice were maintained at 22 C± 2°C with a 12-h light: 
dark cycle. All experiments were conducted during the light 
cycle between 08:00-18:00. Food and water were available at 
libitum. 1-1.5-month-old animals of both sexes were used for 
all the experiments in accordance with ethical regulations and 
the New York University Medical Center (NYUMC) 
guidelines, and approved by the Institutional Animal Care and 
Use Committee (IACUC) at NYUMC. No association was 
found between animals’ sex and experimental results. 
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8.13 In vivo imaging with two-photon microscopy in 









GCamp6f astrocytes were imaged by two-photon 
microscopy, through a small craniotomy (Grutzendler, 
Kasthuri, & Gan, 2002).  
Briefly, adult transgenic mice were anesthetized 
intraperitoneally with ketamine (200 mg/kg body weight) and 
xylazine (30 mg/kg body weight) in 0.9% NaCl solution. For 
imaging through a window in the skull, a thinned region (1–2 
mm in diameter) was opened either with needle or forceps.  
A drop (200 µl) of artificial mouse cerebrospinal fluid 
(ACSF, 125 mM NaCl, 26 mM NaHCO3, 1.25 mM 
NaH2PO4, 2.5 mM KCl, 1.0 mM MgCl2, 2.0 mM CaCl2, 25 
mM glucose; Bubble 95% O2 and 5% CO2 through the 
solution) was applied on the exposed region for the duration 
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of the experiment. The skull surrounding either the thinned 
region or the open skull window was attached to a custom-
made steel plate to reduce respiratory-induced movement. The 
animal was placed under either a Bio-Rad multi-photon 
microscope (Radiance 2001) or a custom-made two-photon 
microscope described previously. The Ti-sapphire laser was 
tuned to the excitation wavelength for GFP (920 nm).  
A stack of image planes with a step size of 0.75–2 µm 
was acquired using a water-immersion objective (Olympus 
60x, 0.9 N.A.; Olympus 25X, N.A. 1.1) at zoom of 1.0–3.0. 




8.14 Surgical preparation for imaging awake, head-
restrained mice 
 
Ciao We performed imaging in awake, head restrained 
mice through a cranial window. 24 h prior to imaging, mice 
underwent surgery to attach a head holder (G. Yang, Pan, 
Chang, Gooden, & Gan, 2013). Specifically, mice were deeply 
anesthetized with an intraperitoneal injection of ketamine (100 
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mg/g) and xylazine (10 mg/g). The mouse head was shaved, 
and the skull surface was exposed with a midline scalp incision.  
The periosteum tissue over the skull surface was 
removed without damaging the temporal and occipital 
muscles. Two parallel micro-metal bars were attached to the 
animal’s skull to serve as the head holder to help restrain the 
animal’s head and reduce motion-induced artifact during 
imaging.  
A skull region of 0.2 mm in diameter was located over 
the primary motor cortex based on stereotactic coordinates (at 
0.2 mm anterior to bregma and 1.2 mm lateral to midline) and 
marked with a pen. Next the head holder was mounted with 
dental acrylic cement (Lang Dental Manufacturing Co., IL, 
USA) such that the marked skull region was exposed between 
the two bars.  
The marked region for imaging was kept exposed, 
uncovered with dental acrylic cement. The next day, we 
created the cranial window over the marked region. Briefly, the 
head holder was screwed to two metal cubes that were 
attached to a solid metal base.  
A high-speed drill was used to carefully reduce the skull 
thickness under a dissecting microscope (skull thickness 
20µm). The skull was immersed in artificial cerebrospinal fluid 
(ACSF) during drilling. For open skull preparation a small 
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circular craniotomy (1.0-1.5 mm diameter) was made and 
covered with a round glass coverslip (World Precision 
Instruments, coverslips, 5mm diameter) custom-made to the 









The coverslip was glued to the skull to reduce motion of 
the exposed brain. Before imaging, mice were given 1 day to 
recover from the surgery related anesthesia and habituated for 
a few times (10 min each) in the imaging apparatus to 
minimize potential stress effects due to head restraining and 
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8.15 Drug through an open window in the skull 
 
Various reagents were dissolved in ACSF (artificial 
cerebrospinal fluid), and a small drop of the solution (200 µl) 
containing the compound of interest was applied directly onto 
the cortex through the open window after removing the dura.  
Imaging started either right away for anesthetized 
experiments or 10 min after drug application for awake head 
restrained experiments. Drugs: NGF (200-1000ng/ml), 
proNGF (400-1000 ng/ml), Phenilephrine (Sigma, 100 nM), 
anti-NGF clone αD11 (8µg/ml), anti- TrkAFc (1µg/ml, R&D 
Systems). The NT condition in all in vivo experiments stands 
for “ACSF only”. 
 
8.16 Statistical analyses for in vivo Ca2+ experiments 
 
All imaging data were presented as mean ± s.e.m. 
Student's t-test (two-tailed) was used to test for differences 
between groups whose distributions passed tests for normality 
(Kolmogorov–Smirnov).  
Wilcoxon matched-pairs signed rank test and Mann–
Whitney U test were used to analyze those groups whose 
distributions did not pass tests for normality.  
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1way ANOVA was used when confronting groups n>2. 
2way ANOVA was used when confronting traces to take into 
account time, treatment and replicates.  
Significant levels were set at P ≤ 0.05. All statistical 
analyses were performed using the GraphPad Prism. 
 
8.17 NGF immunoprecipitation and Western Blot 
 
The scraped astrocytes (see the M&M 8.4 paragraph for 
the input cells treatment and collection) were sonicated, 
incubated in ice for 30 min, and centrifuged at 15,000 × g for 
30 min at 4°C. Protein concentration in the supernatant was 
quantified using the Bradford method (Bio-Rad).  
Four milligrams of protein were immunoprecipitated 
with an excess of anti-NGF αD11 antibody in NET Gel 
Buffer (Tris-HCl, pH 7.5, 50 mm; NaCl 150 mm; 0.1% 
Nonidet P-40; EDTA, pH 8, 1 mm; 0.25% gelatin; and 0.02% 
NaN).  
After immunoprecipitation, total lysates were loaded on 
12% acrylamide gels and blotted using nitrocellulose 
membranes. The primary antibody was anti-NGF M20 (1:500; 
Santa Cruz Biotechnology), the secondary antibody was goat 
anti-rabbit HRP-conjugated (1:500; Santa Cruz 
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Biotechnology). Blot images were acquired using a ChemiDoc 
System (Bio-Rad), and the optical density was quantified using 
ImageJ (NIH). 
 
























Rat hippocampus stained with antibody to NeuN (green), myelin basic protein 
(red) and DAPI (blue). 
Credit: GerryShaw, 2015. 
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